Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Previous issues

Page Path
HOME > BROWSE ARTICLES > Previous issues
26 Previous issues
Filter
Filter
Article type
Keywords
Authors
Volume 29(3); September 2014
Prev issue Next issue
Review Articles
Thyroid
Molecular Pathogenesis and Targeted Therapies in Well-Differentiated Thyroid Carcinoma
Jung Guk Kim
Endocrinol Metab. 2014;29(3):211-216.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.211
  • 4,145 View
  • 38 Download
  • 12 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   

Four proto-oncogenes commonly associated with well-differentiated thyroid carcinoma, rearranged during transfection (RET)/papillary thyroid cancer, BRAF, RAS, and PAX8/peroxisome proliferator activated receptor-γ, may carry diagnostic and prognostic significance. These oncogenes can be used to improve the diagnosis and management of well-differentiated thyroid carcinoma. Limited therapeutic options are available for patients with metastatic well-differentiated thyroid cancer, necessitating the development of novel therapies. Vascular endothelial growth factor (VEGF)- and RET-directed therapies such as sorafenib, motesanib, and sunitinib have been shown to be the most effective at inducing clinical responses and stabilizing the disease process. Further clinical trials of these therapeutic agents may soon change the management of thyroid cancer.

Citations

Citations to this article as recorded by  
  • Estimating the Growth Rate of Lung Metastases in Differentiated Thyroid Carcinoma: Response Evaluation Criteria in Solid Tumors or Doubling Time?
    Eyun Song, Jonghwa Ahn, Min Ji Jeon, Sang Min Lee, Jeong Hyun Lee, Tae Yong Kim, Jung Hwan Baek, Won Bae Kim, Young Kee Shong, Won Gu Kim
    Thyroid.2020; 30(3): 418.     CrossRef
  • Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in Korea
    Eyun Song, Mijin Kim, Eui Young Kim, Bo Hyun Kim, Dong Yeob Shin, Ho-Cheol Kang, Byeong-Cheol Ahn, Won Bae Kim, Young Kee Shong, Min Ji Jeon, Dong Jun Lim
    Thyroid.2020; 30(5): 732.     CrossRef
  • The role of Slit2 as a tumor suppressor in thyroid cancer
    Min Ji Jeon, Seonhee Lim, Mi-hyeon You, Yangsoon Park, Dong Eun Song, Soyoung Sim, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Won Gu Kim
    Molecular and Cellular Endocrinology.2019; 483: 87.     CrossRef
  • Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study
    Hye-Seon Oh, Dong Yeob Shin, Mijin Kim, So Young Park, Tae Hyuk Kim, Bo Hyun Kim, Eui Young Kim, Won Bae Kim, Jae Hoon Chung, Young Kee Shong, Dong Jun Lim, Won Gu Kim
    Thyroid.2019; 29(12): 1804.     CrossRef
  • Cytological features of warthin‐like papillary thyroid carcinoma: A case report with review of previous cytology cases
    Archana George Vallonthaiel, Shipra Agarwal, Deepali Jain, Rajni Yadav, Nishikant A. Damle
    Diagnostic Cytopathology.2017; 45(9): 837.     CrossRef
  • Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma
    Min Ji Jeon, Won Gu Kim, Soyoung Sim, Seonhee Lim, Hyemi Kwon, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Endocrinology and Metabolism.2016; 31(1): 100.     CrossRef
  • Molecular Diagnosis Using Residual Liquid-Based Cytology Materials for Patients with Nondiagnostic or Indeterminate Thyroid Nodules
    Hyemi Kwon, Won Gu Kim, Markus Eszlinger, Ralf Paschke, Dong Eun Song, Mijin Kim, Suyeon Park, Min Ji Jeon, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Endocrinology and Metabolism.2016; 31(4): 586.     CrossRef
  • Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells
    Min Ji Jeon, Won Gu Kim, Seonhee Lim, Hyun-Jeung Choi, Soyoung Sim, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Molecular and Cellular Endocrinology.2016; 419: 113.     CrossRef
  • Upregulation of long noncoding RNA LOC100507661 promotes tumor aggressiveness in thyroid cancer
    Daham Kim, Woo Kyung Lee, Seonhyang Jeong, Mi-Youn Seol, Hyunji Kim, Kyung-Sup Kim, Eun Jig Lee, Jandee Lee, Young Suk Jo
    Molecular and Cellular Endocrinology.2016; 431: 36.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer
Thyroid
Current Status and Future Perspectives in Differentiated Thyroid Cancer
Tae Yong Kim, Won Gu Kim, Won Bae Kim, Young Kee Shong
Endocrinol Metab. 2014;29(3):217-225.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.217
  • 5,130 View
  • 39 Download
  • 76 Web of Science
  • 62 Crossref
AbstractAbstract PDFPubReader   

Thyroid cancer is increasing all over the world. The exact cause of this increase is still debated and there are conflicting reports. Sophisticated molecular studies suggest that environmental chemicals may have effects of thyroid carcinogenesis. The development of powerful molecular biology techniques has enabled targeted next-generation sequencing for detection of mutations in thyroid cancer, and this technique can make a specific diagnosis of thyroid cancer in cytologically indeterminate cases. The initial treatment of well-differentiated thyroid cancer (DTC) is surgery followed by radioiodine remnant ablation. However, further studies are needed to determine the optimal dosage of radioactive iodine for DTC patients with lateral neck metastasis. DTC is an indolent tumor and may cause death even decades later. Thus, long-term follow-up is mandatory. Recently, dynamic risk stratification (DRS) has begun to use stimulated thyroglobulin level at 1 year after the initial treatment and restratified the risk in accordance with the response to the initial treatment. This DRS strategy accurately predicts disease free survival and can be widely used in daily clinical settings. For the iodine refractory metastatic disease, redifferentiation therapy and targeted therapy are two promising alternative treatments. Sorafenib is the first approved agent for the treatment of progressive iodine refractory advanced thyroid cancer in Korea and may be very helpful for radioactive-refractory locally advanced or metastatic DTC. Selumetinib may be an effective redifferentiating agent and could be used within several years.

Citations

Citations to this article as recorded by  
  • Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea
    Hyemi Kwon, Kyung-Do Han, Sun Joon Moon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1095.     CrossRef
  • Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids
    Hélène Lasolle, Andrea Schiavo, Adrien Tourneur, Pierre Gillotay, Bárbara de Faria da Fonseca, Lucieli Ceolin, Olivier Monestier, Benilda Aganahi, Laura Chomette, Marina Malta Letro Kizys, Lieven Haenebalcke, Tim Pieters, Steven Goossens, Jody Haigh, Vinc
    Oncogene.2024; 43(3): 155.     CrossRef
  • Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation
    Jing-Yang Su
    American Journal of Cancer Research.2024; 14(2): 407.     CrossRef
  • Clinical significance and diagnostic value of QPCT, SCEL and TNFRSF12A in papillary thyroid cancer
    Tairong Liang, Xiuqian Wu, Lan Wang, Zhengzhong Ni, Ying Fan, Peishan Wu, Hongzhi Wang, Yongdong Niu, Haihua Huang
    Pathology - Research and Practice.2023; 245: 154431.     CrossRef
  • Thyroidkeeper: a healthcare management system for patients with thyroid diseases
    Jing Zhang, Jianhua Li, Yi Zhu, Yu Fu, Lixia Chen
    Health Information Science and Systems.2023;[Epub]     CrossRef
  • Repeated Low High-Density Lipoprotein Cholesterol and the Risk of Thyroid Cancer: A Nationwide Population- Based Study in Korea
    Jinyoung Kim, Mee Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Kyungdo Han, Hyuk-Sang Kwon
    Endocrinology and Metabolism.2022; 37(2): 303.     CrossRef
  • Comparison of the prognostic value of AJCC cancer staging system 7th and 8th editions for differentiated thyroid cancer
    Y. J. Morosán Allo, L. Bosio, A. Morejón, C. Parisi, M. C. Faingold, V. Ilera, A. Gauna, G. Brenta
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • Immune Profiling of Advanced Thyroid Cancers Using Fluorescent Multiplex Immunohistochemistry
    Jonghwa Ahn, Meihua Jin, Eyun Song, Yeon-mi Ryu, Dong Eun Song, Sang-Yeob Kim, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon, Won Gu Kim
    Thyroid.2021; 31(1): 61.     CrossRef
  • A double mutation of BRAF L597Q and V600E in situ and solitary brain metastasis of occult papillary thyroid carcinoma
    Ling Chen, Yue Wu, Huili Bai, Huandong Liu, Xiaosong Li
    Medicine.2021; 100(6): e24458.     CrossRef
  • Mutation in Genes Encoding Key Functional Groups Additively Increase Mortality in Patients with BRAFV600E-Mutant Advanced Papillary Thyroid Carcinoma
    Eyun Song, Meihua Jin, Ahreum Jang, Min Ji Jeon, Dong Eun Song, Hye Jin Yoo, Won Bae Kim, Young Kee Shong, Won Gu Kim
    Cancers.2021; 13(22): 5846.     CrossRef
  • Current Status and Future Perspective of the Treatment for Radioiodine Refractory Differentiated Thyroid Cancer
    Young Kee Shong
    International Journal of Thyroidology.2021; 14(2): 98.     CrossRef
  • Comprehensive evaluation of risk factors for lymph node metastasis in patients with papillary thyroid carcinoma
    Yan Dong, Dan Wang, Yisheng Luo, Ling Chen, Huili Bai, Yifan Shen, Yangli Zhang, Xueping Chen, Xinliang Su, Jinqiu Zhao, Huandong Liu, Jungao Lu, Zuoyi Yao, Yajing Zhao, Changlong He, Xiaosong Li
    Oncology Letters.2021;[Epub]     CrossRef
  • Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in Korea
    Eyun Song, Mijin Kim, Eui Young Kim, Bo Hyun Kim, Dong Yeob Shin, Ho-Cheol Kang, Byeong-Cheol Ahn, Won Bae Kim, Young Kee Shong, Min Ji Jeon, Dong Jun Lim
    Thyroid.2020; 30(5): 732.     CrossRef
  • Radioiodine ablation in thyroid cancer patients: renal function and external radiation dose rate at discharge according to patient preparation
    Yeon-Hee Han, Hwan-Jeong Jeong, Myung-Hee Sohn, Sun Y. Lee, Seok T. Lim
    The Quarterly Journal of Nuclear Medicine and Molecular Imaging.2020;[Epub]     CrossRef
  • Metabolic Syndrome and the Risk of Thyroid Cancer: A Nationwide Population-Based Cohort Study
    Joo-Hyun Park, Moonyoung Choi, Jung-Hun Kim, Jaemin Kim, Kyungdo Han, Bongsung Kim, Do-Hoon Kim, Yong-Gyu Park
    Thyroid.2020; 30(10): 1496.     CrossRef
  • Serum Adiponectin and Progranulin Level in Patients with Benign Thyroid Nodule or Papillary Thyroid Cancer
    Hyemi Kwon, Se Eun Park, Ji-Sup Yun, Cheol-Young Park
    Endocrinology and Metabolism.2020; 35(2): 396.     CrossRef
  • The role of Slit2 as a tumor suppressor in thyroid cancer
    Min Ji Jeon, Seonhee Lim, Mi-hyeon You, Yangsoon Park, Dong Eun Song, Soyoung Sim, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Won Gu Kim
    Molecular and Cellular Endocrinology.2019; 483: 87.     CrossRef
  • Metabolic Obesity Phenotypes and Thyroid Cancer Risk: A Cohort Study
    Hyemi Kwon, Yoosoo Chang, Ara Cho, Jiin Ahn, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Hocheol Shin, Seungho Ryu, Eun-Jung Rhee
    Thyroid.2019; 29(3): 349.     CrossRef
  • Impact of delayed radioiodine therapy in intermediate‐/high‐risk papillary thyroid carcinoma
    Mijin Kim, Minkyu Han, Min Ji Jeon, Won Gu Kim, In Joo Kim, Jin‐Sook Ryu, Won Bae Kim, Young Kee Shong, Tae Yong Kim, Bo Hyun Kim
    Clinical Endocrinology.2019; 91(3): 449.     CrossRef
  • Myxedema coma precipitated by diabetic ketoacidosis after total thyroidectomy: a case report
    Jin Joo Kim, Eun Young Kim
    Journal of Medical Case Reports.2019;[Epub]     CrossRef
  • Comprehensive analysis for diagnosis of preoperative non-invasive follicular thyroid neoplasm with papillary-like nuclear features
    Hye Seung Lee, Jae-Wook Lee, Ji Hyun Park, Wan-Seop Kim, Hye Seung Han, Seung Eun Lee, Paula Soares
    PLOS ONE.2019; 14(7): e0218046.     CrossRef
  • Rutin Scavenges Reactive Oxygen Species, Inactivates 5′-Adenosine Monophosphate-Activated Protein Kinase, and Increases Sodium–Iodide Symporter Expression in Thyroid PCCL3 Cells
    Carlos Frederico Lima Gonçalves, Mariana Lopes de Freitas, Rodrigo Soares Fortunato, Leandro Miranda-Alves, Denise P. Carvalho, Andrea Claudia Freitas Ferreira
    Thyroid.2018; 28(2): 265.     CrossRef
  • Prevalence ofBRAFV600EMutation in Follicular Variant of Papillary Thyroid Carcinoma and Non-Invasive Follicular Tumor with Papillary-Like Nuclear Features (NIFTP) in aBRAFV600EPrevalent Area
    Hyereen Kim, Bo Hyun Kim, Young Keum Kim, Jeong Mi Kim, Seo Young Oh, Eun Heui Kim, Min Jin Lee, Jong Ho Kim, Yun Kyung Jeon, Sang Soo Kim, Byung Joo Lee, Yong Ki Kim, In Joo Kim
    Journal of Korean Medical Science.2018;[Epub]     CrossRef
  • Whole-Exome Sequencing Identifies Two Discrete Druggable Signaling Pathways in Follicular Thyroid Cancer
    Neeta J. Erinjeri, Norman G. Nicolson, Christine Deyholos, Reju Korah, Tobias Carling
    Journal of the American College of Surgeons.2018; 226(6): 950.     CrossRef
  • Efficacy and Affecting Factors of 131I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
    Chen Wang, Hongcui Diao, Ping Ren, Xufu Wang, Yangang Wang, Wenjuan Zhao
    Frontiers in Oncology.2018;[Epub]     CrossRef
  • Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
    Eyun Song, Min Ji Jeon, Hye-Seon Oh, Minkyu Han, Yu-Mi Lee, Tae Yong Kim, Ki-Wook Chung, Won Bae Kim, Young Kee Shong, Dong Eun Song, Won Gu Kim
    European Journal of Endocrinology.2018; 179(3): 135.     CrossRef
  • SPC24 is critical for anaplastic thyroid cancer progression
    Huabin Yin, Tong Meng, Lei Zhou, Haiyan Chen, Dianwen Song
    Oncotarget.2017; 8(13): 21884.     CrossRef
  • Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis
    Renfei Wang, Yueqian Zhang, Jian Tan, Guizhi Zhang, Ruiguo Zhang, Wei Zheng, Yajing He
    Medicine.2017; 96(19): e6809.     CrossRef
  • Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication
    Hye In Kim, Tae Hyuk Kim, Hosu Kim, Young Nam Kim, Hye Won Jang, Jae Hoon Chung, Seong Mi Moon, Byung Woo Jhun, Hyun Lee, Won-Jung Koh, Sun Wook Kim, Dongmei Li
    PLOS ONE.2017; 12(1): e0169775.     CrossRef
  • DelayedTSHrecovery after dose adjustment duringTSH‐suppressive levothyroxine therapy of thyroid cancer
    Hye In Kim, Tae Hyuk Kim, Hosu Kim, Young Nam Kim, Hye Won Jang, Jung‐Han Kim, Kyu Yeon Hur, Jae Hoon Chung, Sun Wook Kim
    Clinical Endocrinology.2017; 87(3): 286.     CrossRef
  • Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease
    Yun Mi Choi, Won Gu Kim, Tae Yong Kim, Sung Jin Bae, Hong-Kyu Kim, Eun Kyung Jang, Min Ji Jeon, Ji Min Han, Young Kee Shong, Won Bae Kim
    The Korean Journal of Internal Medicine.2017; 32(1): 102.     CrossRef
  • Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?
    Mijin Kim, Young Nam Kim, Won Gu Kim, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Hyeon Seon Ahn, Sin-Ho Jung, Sun Wook Kim, Won Bae Kim, Jae Hoon Chung, Young Kee Shong, Tae Hyuk Kim, Tae Yong Kim
    Clinical Endocrinology.2017; 86(3): 438.     CrossRef
  • Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung
    Mijin Kim, Won Gu Kim, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Jong Jin Lee, Jin-Sook Ryu, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Thyroid.2017; 27(1): 49.     CrossRef
  • Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations
    Tae Hyuk Kim, Chang-Seok Ki, Hye Seung Kim, Kyunga Kim, Jun-Ho Choe, Jung-Han Kim, Jee Soo Kim, Young Lyun Oh, Soo Yeon Hahn, Jung Hee Shin, Hye Won Jang, Sun Wook Kim, Jae Hoon Chung
    The Journal of Clinical Endocrinology & Metabolism.2017; 102(5): 1757.     CrossRef
  • Comparison of the Seventh and Eighth Editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer
    Mijin Kim, Won Gu Kim, Hye-Seon Oh, Suyeon Park, Hyemi Kwon, Dong Eun Song, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Tae-Yon Sung, Min Ji Jeon
    Thyroid.2017; 27(9): 1149.     CrossRef
  • Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma
    Mijin Kim, Won Gu Kim, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Sang Min Lee, Jeong Hyun Lee, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Thyroid.2017; 27(7): 915.     CrossRef
  • Preoperative clinicopathological characteristics of patients with solitary encapsulated follicular variants of papillary thyroid carcinomas
    Hyemi Kwon, Min Ji Jeon, Jong Ho Yoon, Suck Joon Hong, Jeong Hyun Lee, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Won Gu Kim, Dong Eun Song
    Journal of Surgical Oncology.2017; 116(6): 746.     CrossRef
  • Prescribed Activity of 131I Therapy in Differentiated Thyroid Cancer
    Douglas Van Nostrand
    Journal of Nuclear Medicine.2017; 58(5): 697.     CrossRef
  • Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy
    Xingchen Shang, Xia Zhong, Xingsong Tian
    Tumor Biology.2016; 37(8): 11163.     CrossRef
  • Recent Updates on the Management of Medullary Thyroid Carcinoma
    Bo Hyun Kim, In Joo Kim
    Endocrinology and Metabolism.2016; 31(3): 392.     CrossRef
  • Intraoperative Near‐infrared Imaging for Parathyroid Gland Identification by Auto‐fluorescence: A Feasibility Study
    Frederic De Leeuw, Ingrid Breuskin, Muriel Abbaci, Odile Casiraghi, Haïtham Mirghani, Aïcha Ben Lakhdar, Corinne Laplace‐Builhé, Dana Hartl
    World Journal of Surgery.2016; 40(9): 2131.     CrossRef
  • Papillary thyroid carcinoma: different clinical behavior among pT3 tumors
    Maria Joana Santos, Maria João Bugalho
    Endocrine.2016; 53(3): 754.     CrossRef
  • Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma
    Hyemi Kwon, Won Gu Kim, Tae‐Yon Sung, Min Ji Jeon, Dong Eun Song, Yu‐Mi Lee, Jong Ho Yoon, Ki‐Wook Chung, Suck Joon Hong, Jung Hwan Baek, Jeong Hyun Lee, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Journal of Surgical Oncology.2016; 113(2): 152.     CrossRef
  • Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed tomography
    BIN LONG, MENGDI YANG, ZHIWEN YANG, HEQING YI, LINFA LI
    Oncology Letters.2016; 11(2): 965.     CrossRef
  • Usefulness of PET/CT in the diagnosis of recurrent or metastasized differentiated thyroid carcinoma
    CUN-ZHI LU, SU-SHENG CAO, WEI WANG, JUN LIU, NING FU, FENG LU
    Oncology Letters.2016; 11(4): 2420.     CrossRef
  • Coexistence of papillary thyroid microcarcinoma and mucosa-associated lymphoid tissue lymphoma in a context of Hashimoto's thyroiditis
    Saul Levy-Blitchtein, Stefany Plasencia-Rebata, Domingo Morales Luna, Juana del Valle Mendoza
    Asian Pacific Journal of Tropical Medicine.2016; 9(8): 812.     CrossRef
  • Iodine-131 Therapy and Nasolacrimal Duct Obstructions: What We Know and What We Need to Know
    Mohammad Javed Ali
    Ophthalmic Plastic & Reconstructive Surgery.2016; 32(4): 243.     CrossRef
  • Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma
    Min Ji Jeon, Won Gu Kim, Soyoung Sim, Seonhee Lim, Hyemi Kwon, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Endocrinology and Metabolism.2016; 31(1): 100.     CrossRef
  • Dietary evaluation of a low-iodine diet in Korean thyroid cancer patients preparing for radioactive iodine therapy in an iodine-rich region
    Dal Lae Ju, Young Joo Park, Hee-Young Paik, Min-Ji Kim, Seonyeong Park, Kyong Yeun Jung, Tae Hyuk Kim, Hun Sung Choi, Yoon Ju Song
    Nutrition Research and Practice.2016; 10(2): 167.     CrossRef
  • Features Predictive of Distant Metastasis in Papillary Thyroid Microcarcinomas
    Min Ji Jeon, Won Gu Kim, Yun Mi Choi, Hyemi Kwon, Yu-Mi Lee, Tae-Yon Sung, Jong Ho Yoon, Ki-Wook Chung, Suck Joon Hong, Tae Yong Kim, Young Kee Shong, Dong Eun Song, Won Bae Kim
    Thyroid.2016; 26(1): 161.     CrossRef
  • Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells
    Min Ji Jeon, Won Gu Kim, Seonhee Lim, Hyun-Jeung Choi, Soyoung Sim, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Molecular and Cellular Endocrinology.2016; 419: 113.     CrossRef
  • Differentiated Thyroid Cancer in Asians
    Bo Hyun Kim
    Endocrinology and Metabolism.2016; 31(1): 62.     CrossRef
  • Sub-Classification of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma by Pathologic Criteria
    Min Ji Jeon, Won Gu Kim, Eun Kyung Jang, Yun Mi Choi, Dong Eun Song, Tae-Yon Sung, Jong Ho Yoon, Ki-Wook Chung, Suck Joon Hong, Jin-Sook Ryu, Ji Min Han, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Konradin Metze
    PLOS ONE.2015; 10(7): e0133625.     CrossRef
  • The Impact of Low Adherence to the Low-iodine Diet on the Efficacy of the Radioactive Iodine Ablation Therapy
    Dal Lae Ju, Young Joo Park, Hee-Young Paik, YoonJu Song
    Clinical Nutrition Research.2015; 4(4): 267.     CrossRef
  • High metabolic tumor volume and total lesion glycolysis are associated with lateral lymph node metastasis in patients with incidentally detected thyroid carcinoma
    Bo Hyun Kim, Seong-Jang Kim, Keunyoung Kim, Heeyoung Kim, So Jung Kim, Won Jin Kim, Yun Kyung Jeon, Sang Soo Kim, Yong Ki Kim, In Joo Kim
    Annals of Nuclear Medicine.2015; 29(8): 721.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Changes in the Pulmonary Function Test after Radioactive Iodine Treatment in Patients with Pulmonary Metastases of Differentiated Thyroid Cancer
    Eun Kyung Jang, Won Gu Kim, Ho-Cheol Kim, Jin-Won Huh, Hyemi Kwon, Yun Mi Choi, Min Ji Jeon, Tae Yong Kim, Young Kee Shong, Jin-Sook Ryu, Won Bae Kim, Karen M. Tordjman
    PLOS ONE.2015; 10(4): e0125114.     CrossRef
  • Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma
    Tae Yon Sung, Mijin Kim, Tae Yong Kim, Won Gu Kim, Yangsoon Park, Dong Eun Song, Su-Yeon Park, Hyemi Kwon, Yun Mi Choi, Eun Kyung Jang, Min Ji Jeon, Young Kee Shong, Suck Joon Hong, Won Bae Kim
    Thyroid.2015; 25(9): 1020.     CrossRef
  • Thyroglobulin Level in Fine-Needle Aspirates for Preoperative Diagnosis of Cervical Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma: Two Different Cutoff Values According to Serum Thyroglobulin Level
    Min Ji Jeon, Won Gu Kim, Eun Kyung Jang, Yun Mi Choi, Yu-Mi Lee, Tae-Yon Sung, Jong Ho Yoon, Ki-Wook Chung, Suck Joon Hong, Jung Hwan Baek, Jeong Hyun Lee, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Thyroid.2015; 25(4): 410.     CrossRef
  • A Closer Look at Papillary Thyroid Carcinoma
    Won Bae Kim
    Endocrinology and Metabolism.2015; 30(1): 1.     CrossRef
  • Protecting the normal in order to better kill the cancer
    Bingya Liu, Lewis Ezeogu, Lucas Zellmer, Baofa Yu, Ningzhi Xu, Dezhong Joshua Liao
    Cancer Medicine.2015; 4(9): 1394.     CrossRef
  • Recent Changes in the Clinical Outcome of Papillary Thyroid Carcinoma With Cervical Lymph Node Metastasis
    Min Ji Jeon, Won Gu Kim, Yun Mi Choi, Hyemi Kwon, Dong Eun Song, Yu-Mi Lee, Tae-Yon Sung, Jong Ho Yoon, Suck Joon Hong, Jung Hwan Baek, Jeong Hyun Lee, Jin-Sook Ryu, Tae Yong Kim, Young Kee Shong, Ki-Wook Chung, Won Bae Kim
    The Journal of Clinical Endocrinology & Metabolism.2015; 100(9): 3470.     CrossRef
Close layer
Thyroid
Can Robotic Thyroidectomy Be Performed Safely in Thyroid Carcinoma Patients?
Young Jun Chai, Kyu Eun Lee, Yeo-Kyu Youn
Endocrinol Metab. 2014;29(3):226-232.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.226
  • 5,349 View
  • 43 Download
  • 21 Web of Science
  • 21 Crossref
AbstractAbstract PDFPubReader   

Since the adoption of the Da Vinci robotic system for remote access thyroid surgery, robotic thyroidectomy (RT) has become a popular surgical option for patients who want to avoid neck scars. Surgeons in South Korea pioneered this surgical technique and have reported successful outcomes. Although many studies have reported that RT is a feasible and safe therapeutic alternative, concerns over the surgical and oncological safety of RT remain. This article reviews the advantages and disadvantages of RT and compares the surgical safety and oncological completeness of RT with conventional open thyroidectomy.

Citations

Citations to this article as recorded by  
  • Transoral robotic thyroidectomy: Lessons learned from consecutive series of 1,000 patients
    Moon Young Oh, Dawon Park, Young Jun Chai, Kwangsoon Kim, Hoon Yub Kim
    Surgery.2024; 176(6): 1627.     CrossRef
  • Comparative surgical outcomes of transoral endoscopic and robotic thyroidectomy for thyroid carcinoma: a propensity score-matched analysis
    Min Jung Lee, Moon Young Oh, Jung-Man Lee, Jiyu Sun, Young Jun Chai
    Surgical Endoscopy.2023; 37(2): 1132.     CrossRef
  • Comparison of surgical completeness in patients operated on conventional open total thyroidectomy (OT) or trans-axillary robot-assisted total thyroidectomy (RATT) by a single axillary approach
    Valeria Matteucci, Lorenzo Fregoli, Piermarco Papini, Leonardo Rossi, Antonio Matrone, Mario Miccoli, Rossella Elisei, Gabriele Materazzi
    Updates in Surgery.2023; 75(5): 1267.     CrossRef
  • Bilateral axillo-breast approach robotic thyroidectomy (BABA-RT) versus transoral robotic thyroidectomy (TORT): a systematic review and meta-analysis
    Ebraheem Albazee, Ahmed Abdelaziz, Reham Alabdulhadi, Danah Ibrahim Alkandari, Aysha Abduljabbar, Sara Sulaiman, Mohammad Alnifise, Jasem Ameen, Houda Magzoub, Karim Alomar, Shaima Ali Maghdi, Ahmed Abu-Zaid
    Updates in Surgery.2023; 75(5): 1277.     CrossRef
  • Transoral endoscopic thyroidectomy vestibular approach vs. transoral robotic thyroidectomy: systematic review and meta-analysis
    Moon Young Oh, Young Jun Chai, Hyeong Won Yu, Su-Jin Kim, June Young Choi, Kyu Eun Lee
    Updates in Surgery.2023; 75(7): 1773.     CrossRef
  • Transoral Endoscopic Thyroidectomy by Vestibular Approach with Central Lymph Node Dissection for Thyroid Microcarcinoma
    Hau Xuan Nguyen, Hien Xuan Nguyen, Hung Van Nguyen, Long Thanh Nguyen, Thao Thi Phuong Nguyen, Quang Van Le
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2021; 31(4): 410.     CrossRef
  • Robotik in der Kopf-Hals-Chirurgie
    P. J. Schuler, F. Boehm, L. R. Schild, J. Greve, T. K. Hoffmann
    HNO.2021; 69(2): 131.     CrossRef
  • Current Advances in Robotics for Head and Neck Surgery—A Systematic Review
    Felix Boehm, Rene Graesslin, Marie-Nicole Theodoraki, Leon Schild, Jens Greve, Thomas K. Hoffmann, Patrick J. Schuler
    Cancers.2021; 13(6): 1398.     CrossRef
  • Institutional experience of 200 consecutive papillary thyroid carcinoma patients in transoral robotic thyroidectomy surgeries
    Dawon Park, Hoon Yub Kim, Hong Kyu Kim, Ji‐Young You, Gianlorenzo Dionigi, Jonathon O. Russell, Ralph P. Tufano
    Head & Neck.2020; 42(8): 2106.     CrossRef
  • Transoral Robotic Thyroidectomy for Papillary Thyroid Carcinoma: Perioperative Outcomes of 100 Consecutive Patients
    Hong Kyu Kim, Young Jun Chai, Gianlorenzo Dionigi, Eren Berber, Ralph P. Tufano, Hoon Yub Kim
    World Journal of Surgery.2019; 43(4): 1038.     CrossRef
  • Endoscopic interventions on the thyroid gland, as operations in a potential workspace
    M. Sh. Mamistvalov, I. A. Kurganov, S. I. Emelyanov, D. Yu. Bogdanov, D. V. Lukyanchenko
    Endoskopicheskaya khirurgiya.2019; 25(5): 54.     CrossRef
  • Robotic Thyroidectomy Decreases Postoperative Pain Compared With Conventional Thyroidectomy
    Min Kyoung Kim, Hyun Kang, Geun Joo Choi, Kyung Ho Kang
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2019; 29(4): 255.     CrossRef
  • Comparative analysis of 2 robotic thyroidectomy procedures: Transoral versus bilateral axillo‐breast approach
    Young Jun Chai, Hoon Yub Kim, Hong Kyu Kim, Sang Ho Jun, Gianlorenzo Dionigi, Angkoon Anuwong, Jeremy D. Richmon, Ralph P. Tufano
    Head & Neck.2018; 40(5): 886.     CrossRef
  • Robotic-assisted modified radical neck dissection using a bilateral axillo-breast approach (robotic BABA MRND) for papillary thyroid carcinoma with lateral lymph node metastasis
    Hyeong Won Yu, Young Jun Chai, Su-jin Kim, June Young Choi, Kyu Eun Lee
    Surgical Endoscopy.2018; 32(5): 2322.     CrossRef
  • Recent advances in robot‐assisted head and neck surgery
    Daniel T. Friedrich, Marc O. Scheithauer, Jens Greve, Thomas K. Hoffmann, Patrick J. Schuler
    The International Journal of Medical Robotics and Computer Assisted Surgery.2017;[Epub]     CrossRef
  • Surgical safety and oncological completeness of robotic thyroidectomy for thyroid carcinoma larger than 2 cm
    Young Jun Chai, Hyunsuk Suh, Jung-Woo Woo, Hyeong Won Yu, Ra-Yeong Song, Hyungju Kwon, Kyu Eun Lee
    Surgical Endoscopy.2017; 31(3): 1235.     CrossRef
  • Experience of transaxillary endoscopic thyroid surgery
    V. K. Lyadov, M. V. Neklyudova, D. R. Pashayeva
    Khirurgiya. Zhurnal im. N.I. Pirogova.2016; (11): 4.     CrossRef
  • Robotergestützte Chirurgie im Kopf-Hals-Bereich
    T. K. Hoffmann, D. T. Friedrich, P. J. Schuler
    HNO.2016; 64(9): 658.     CrossRef
  • Management of Thyroid Nodules
    Ashokkumar Sithamparapillai
    Journal of Otolaryngology-ENT Research.2016;[Epub]     CrossRef
  • Ethical Issues in Robotic-Assisted Transaxillary Thyroidectomy
    Peter Angelos
    International Journal of Endocrine Oncology.2015; 2(2): 129.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer
Thyroid
Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
June-Key Chung, Gi Jeong Cheon
Endocrinol Metab. 2014;29(3):233-239.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.233
  • 6,121 View
  • 90 Download
  • 34 Web of Science
  • 34 Crossref
AbstractAbstract PDFPubReader   

Iodide uptake across the membranes of thyroid follicular cells and cancer cells occurs through an active transport process mediated by the sodium-iodide symporter (NIS). The rat and human NIS-coding genes were cloned and identified in 1996. Evaluation of NIS gene and protein expression is critical for the management of thyroid cancer, and several approaches to increase NIS levels have been tried. Identification of the NIS gene has provided a means of expanding its role in radionuclide therapy and molecular target-specific theragnosis (therapy and diagnosis using the same molecular target). In this article, we describe the relationship between NIS expression and the thyroid carcinoma treatment using I-131 and alternative therapeutic approaches.

Citations

Citations to this article as recorded by  
  • A Pilot Nonrandomized Controlled Trial Examining the Use of Artificial Tears on the Radioactivity of Tears After Radioactive Iodine Treatment for Thyroid Cancer
    Irene T. Lee, Jared V. Grice, Xiangyu Ji, Qingxia Chen, Lindsay A. Bischoff, Aaron C. Jessop, Behin Barahimi, Francois Codere, Louise A. Mawn, Rachel K. Sobel
    Thyroid®.2024; 34(1): 82.     CrossRef
  • Research progress of bone metastases: From disease recognition to clinical practice
    Wenbo Yang, Qing Pan, Fuhua Huang, Hongzhi Hu, Zengwu Shao
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Letter to the editor regarding “Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival”
    Maria José Veloza Vega, Manuela Gallo, Gonzalo Ucros, Patricia Bernal
    European Journal of Nuclear Medicine and Molecular Imaging.2022; 49(11): 3622.     CrossRef
  • Factors Associated With Radioactive Iodine Therapy–Acquired Nasolacrimal Duct Obstruction
    Irene T. Lee, Wencong Chen, Qingxia Chen, Heather A. Cole, Lindsay A. Bischoff, Aaron C. Jessop, Rachel K. Sobel
    Endocrine Practice.2022; 28(12): 1210.     CrossRef
  • RNA-Seq transcriptome analysis reveals Maackia amurensis leukoagglutinin has antitumor activity in human anaplastic thyroid cancer cells
    Suna Bektas, Engin Kaptan
    Molecular Biology Reports.2022; 49(10): 9257.     CrossRef
  • Radio-Iodide Treatment: From Molecular Aspects to the Clinical View
    Antonio De la Vieja, Garcilaso Riesco-Eizaguirre
    Cancers.2021; 13(5): 995.     CrossRef
  • Current Status and Future Perspective of the Treatment for Radioiodine Refractory Differentiated Thyroid Cancer
    Young Kee Shong
    International Journal of Thyroidology.2021; 14(2): 98.     CrossRef
  • 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancer
    T. M. Geliashvili, A. V. Vazhenin, T. P. Berezovskaya, N. G. Afanasyeva, E. V. Vasilyeva, P. I. Garbuzov, V. V. Krylov
    Head and Neck Tumors (HNT).2020; 9(4): 10.     CrossRef
  • Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long‐term study
    Marc‐Kevin Le Roux, Nicolas Graillon, Laurent Guyot, David Taieb, Philippe Galli, Yves Godio‐Raboutet, Cyrille Chossegros, Jean‐Marc Foletti
    Head & Neck.2020; 42(11): 3133.     CrossRef
  • β-radiating radionuclides in cancer treatment, novel insight into promising approach
    Samieh Asadian, Hamed Mirzaei, Bagher Aziz Kalantari, Mohamad Reza Davarpanah, Morteza Mohamadi, Anastasia Shpichka, Leila Nasehi, Hamidreza Aboulkheyr Es, Peter Timashev, Mustapha Najimi, Nematollah Gheibi, Moustapha Hassan, Massoud Vosough
    Pharmacological Research.2020; 160: 105070.     CrossRef
  • Peptide Receptor Radionuclide Therapy in Patients With Differentiated Thyroid Cancer
    Dong Yun Lee, Yong-il Kim
    Clinical Nuclear Medicine.2020; 45(8): 604.     CrossRef
  • FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma
    Seo Young Kang, Ji-In Bang, Keon Wook Kang, Ho-young Lee, June-Key Chung, Juri G. Gelovani
    PLOS ONE.2019; 14(6): e0218416.     CrossRef
  • Role of iodide metabolism in physiology and cancer
    Antonio De la Vieja, Pilar Santisteban
    Endocrine-Related Cancer.2018; 25(4): R225.     CrossRef
  • Star-Shaped Intense Uptake of 131I on Whole Body Scans Can Reflect Good Therapeutic Effects of Low-Dose Radioactive Iodine Treatment of 1.1 GBq
    Sung Hye Kong, Jung Ah Lim, Young Shin Song, Shinje Moon, Ye An Kim, Min Joo Kim, Sun Wook Cho, Jae Hoon Moon, Ka Hee Yi, Do Joon Park, Bo Youn Cho, Young Joo Park
    Endocrinology and Metabolism.2018; 33(2): 228.     CrossRef
  • Sodium Iodide Symporter (NIS) in the Management of Patients with Thyroid Carcinoma
    June-Key Chung, Hyun Woo Kim, Haewon Youn, Gi Jeong Cheon
    Nuclear Medicine and Molecular Imaging.2018; 52(5): 325.     CrossRef
  • LARP7 in papillary thyroid carcinoma induces NIS expression through suppression of the SHH signaling pathway
    Xiaomei Sui, Yana Sui, Yonghui Wang
    Molecular Medicine Reports.2018;[Epub]     CrossRef
  • Human sodium iodide transporter gene-mediated imaging and therapy of mouse glioma, comparison between 188Re and 131I
    Rui Guo, Yun Xi, Min Zhang, Ying Miao, Miao Zhang, Biao Li
    Oncology Letters.2018;[Epub]     CrossRef
  • Iodine-131 Therapy and Lacrimal Drainage System Toxicity: Nasal Localization Studies Using Whole Body Nuclear Scintigraphy and SPECT-CT
    Mohammad Javed Ali, Achyut Ram Vyakaranam, Jyotsna Eleshwarapu Rao, Giri Prasad, Palkonda Vijay Anand Reddy
    Ophthalmic Plastic & Reconstructive Surgery.2017; 33(1): 13.     CrossRef
  • Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment
    Hossein Jadvar
    American Journal of Roentgenology.2017; 209(2): 277.     CrossRef
  • Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer
    Arun Upadhyaya, Pingping Zhou, Zhaowei Meng, Peng Wang, Guizhi Zhang, Qiang Jia, Jian Tan, Xue Li, Tianpeng Hu, Na Liu, Sen Wang, Xiaoxia Liu, Huiying Wang, Chunmei Zhang, Fengxiao Zhao, Ziyu Yan, Xiaoran Wang, Xuemeng Zhang, Wan Zhang
    Nuclear Medicine Communications.2017; 38(11): 891.     CrossRef
  • Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer
    Arun Upadhyaya, Zhaowei Meng, Peng Wang, Guizhi Zhang, Qiang Jia, Jian Tan, Xue Li, Tianpeng Hu, Na Liu, Pingping Zhou, Sen Wang, Xiaoxia Liu, Huiying Wang, Chunmei Zhang, Fengxiao Zhao, Ziyu Yan
    Medicine.2017; 96(25): e7164.     CrossRef
  • Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma
    Mijin Kim, Won Gu Kim, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Sang Min Lee, Jeong Hyun Lee, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Thyroid.2017; 27(7): 915.     CrossRef
  • Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung
    Mijin Kim, Won Gu Kim, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Jong Jin Lee, Jin-Sook Ryu, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Thyroid.2017; 27(1): 49.     CrossRef
  • Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting
    Hyemi Kwon, Min Ji Jeon, Won Gu Kim, Suyeon Park, Mijin Kim, Tae Yong Kim, Minkyu Han, Dong Eun Song, Tae-Yon Sung, Jong Ho Yoon, Suck Joon Hong, Jin-Sook Ryu, Young Kee Shong, Won Bae Kim
    Annals of Surgical Oncology.2017; 24(9): 2596.     CrossRef
  • Preparation and evaluation of 131I-quercetin as a novel radiotherapy agent against dedifferentiated thyroid cancer
    Qinghua Xie, Xia Li, Guanquan Wang, Xuan Hou, Yujun Wang, Hongbo Yu, Changfa Qu, Shunzhong Luo, Yali Cui, Chuanqin Xia, Ruibing Wang
    Journal of Radioanalytical and Nuclear Chemistry.2017; 311(3): 1697.     CrossRef
  • Molecular radiotheragnostics in thyroid disease
    Nitasha Singh, Val Lewington
    Clinical Medicine.2017; 17(5): 453.     CrossRef
  • Inhibition of BRD4 suppresses tumor growth and enhances iodine uptake in thyroid cancer
    Xuemei Gao, Xinchao Wu, Xiao Zhang, Wenjuan Hua, Yajing Zhang, Yusufu Maimaiti, Zairong Gao, Yongxue Zhang
    Biochemical and Biophysical Research Communications.2016; 469(3): 679.     CrossRef
  • Hepatoprotective Effect of Dexmedetomidine Against Radioiodine Toxicity in Rats: Evaluation of Oxidative Status and Histopathologic Changes
    Kemal Kismet, Murat Sadic, Yusuf Murat Bag, Hasan Ikbal Atilgan, Gokhan Koca, Ali Kemal Onalan, Mehmet Senes, Seydi Ali Peker, Nihat Yumusak, Meliha Korkmaz
    International Surgery.2016; 101(3-4): 176.     CrossRef
  • FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway
    Siyuan Ma, Qingzhu Wang, Xiaojun Ma, Lina Wu, Feng Guo, Hongfei Ji, Fei Liu, Yanyan Zhao, Guijun Qin
    Tumor Biology.2016; 37(1): 989.     CrossRef
  • Iodine-131 Therapy and Nasolacrimal Duct Obstructions: What We Know and What We Need to Know
    Mohammad Javed Ali
    Ophthalmic Plastic & Reconstructive Surgery.2016; 32(4): 243.     CrossRef
  • I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer
    Rong Lin, Omar Banafea, Jin Ye
    BMC Gastroenterology.2015;[Epub]     CrossRef
  • Sub-Classification of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma by Pathologic Criteria
    Min Ji Jeon, Won Gu Kim, Eun Kyung Jang, Yun Mi Choi, Dong Eun Song, Tae-Yon Sung, Jong Ho Yoon, Ki-Wook Chung, Suck Joon Hong, Jin-Sook Ryu, Ji Min Han, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Konradin Metze
    PLOS ONE.2015; 10(7): e0133625.     CrossRef
  • Targeted Radionuclide Therapy of Human Tumors
    Sergey Gudkov, Natalya Shilyagina, Vladimir Vodeneev, Andrei Zvyagin
    International Journal of Molecular Sciences.2015; 17(1): 33.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer
Thyroid
Effects of Increased Iodine Intake on Thyroid Disorders
Xin Sun, Zhongyan Shan, Weiping Teng
Endocrinol Metab. 2014;29(3):240-247.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.240
  • 14,531 View
  • 166 Download
  • 75 Web of Science
  • 78 Crossref
AbstractAbstract PDFPubReader   

Iodine is a micronutrient essential for the production of thyroid hormones. Iodine deficiency is the most common cause of preventable mental impairment worldwide. Universal salt iodization (USI) has been introduced in many countries as a cost-effective and sustainable way to eliminate iodine deficiency disorders for more than 25 years. Currently, the relationship between USI and iodine excess has attracted more attention. Iodine excess can lead to hypothyroidism and autoimmune thyroiditis, especially for susceptible populations with recurring thyroid disease, the elderly, fetuses, and neonates. Nationwide USI was introduced in China in 1996. This review focused on the effects of iodine excess worldwide and particularly in China.

Citations

Citations to this article as recorded by  
  • Age‐specific thyrotropin references decrease over‐diagnosis of hypothyroidism in elderly patients in iodine‐excessive areas
    Yingchai Zhang, Yu Sun, Zhiwei He, Shuhang Xu, Chao Liu, Yongze Li, Zhongyan Shan, Weiping Teng
    Clinical Endocrinology.2024; 101(5): 549.     CrossRef
  • Comparison of effects of potassium iodide and potassium chloride on structure and physicochemical properties of proteins
    Fuge Niu, Yi Gao, Xinyu Yan, Huabin Liao, Zhe Li, Yanren Cao, Mengdi Zhao, Beibei Wang, Jiao Yu, Weichun Pan
    Journal of Molecular Liquids.2024; 395: 123844.     CrossRef
  • Micronutrients throughout the Life Cycle: Needs and Functions in Health and Disease
    Mohit Kumar, Devesh Kumar, Ankita Sharma, Shivam Bhadauria, Anil Thakur, Amit Bhatia
    Current Nutrition & Food Science.2024; 20(1): 62.     CrossRef
  • Relationship Between Urinary Iodine Concentration and the Prevalence of Thyroid Nodules and Subclinical Hypothyroidism
    Huachao Zhu, Pu Chen, Xi Ding, Yanru Zhao
    Hormone and Metabolic Research.2024; 56(05): 368.     CrossRef
  • Associations of Combined Exposure to Metabolic and Inflammatory Indicators with Thyroid Nodules in Adults: A Nested Case-Control Study
    Xin-Yi Zhu, Xing-Chen Meng, Bei-Jing Cheng, Chun Wang, Jia Wang, Tian-Lin Li, Hui Li, Ke Meng, Ran Liu, Alexander Schreiber
    International Journal of Endocrinology.2024; 2024: 1.     CrossRef
  • Factors associated with inadequate urinary iodine concentration among pregnant women in Mbeya region Tanzania.
    Tedson Lukindo, Ray Masumo, Adam Hancy, Sauli E. John, Heavenlight A. Paulo, Abraham Sanga, Ramadhan Noor, Fatoumata Lankoande, Elifatio Towo, Germana H. Leyna, Gemma Bridge, Raman Bedi
    F1000Research.2024; 10: 858.     CrossRef
  • Synchronous Removal of Fluoride and Iodide on Fe–Mn Binary Oxides Interface: Competitive Adsorption Behaviors and Mechanism
    Nan Wang, He Liang, Meng Zhang, Ruiping Liu, Lina Li, Li Zhao, Huijuan Liu, Jiuhui Qu
    ACS ES&T Engineering.2024; 4(8): 2015.     CrossRef
  • Factors associated with inadequate urinary iodine concentration among pregnant women in Mbeya region Tanzania.
    Tedson Lukindo, Ray Masumo, Adam Hancy, Sauli E. John, Heavenlight A. Paulo, Abraham Sanga, Ramadhan Noor, Fatoumata Lankoande, Elifatio Towo, Germana H. Leyna, Gemma Bridge, Raman Bedi
    F1000Research.2024; 10: 858.     CrossRef
  • STUDY OF THE CONTENT OF VITAMIN C AND IODINE IN THE FRUITS OF ZYZYPHUS JUJUBA MILL
    Y. V. Fokina
    Biosafety and Biotechnology.2024; (15): 35.     CrossRef
  • Thyroid-Stimulating Hormone Levels within the Trimester-Specific Reference Intervals Are Correlated with Non–High-Density Lipoprotein Cholesterol and Remnant Cholesterol Concentrations in Pregnant Women
    Guocheng Wang, Feng Jin, Limin Xie, Xiaofen Zhang, Yawei Zhang, Xin Ni, Wei Li, Guojun Zhang
    Laboratory Medicine.2023; 54(5): 449.     CrossRef
  • Factors associated with inadequate urinary iodine concentration among pregnant women in Mbeya region Tanzania.
    Tedson Lukindo, Ray Masumo, Adam Hancy, Sauli E. John, Heavenlight A. Paulo, Abraham Sanga, Ramadhan Noor, Fatoumata Lankoande, Elifatio Towo, Germana H. Leyna, Gemma Bridge, Raman Bedi
    F1000Research.2023; 10: 858.     CrossRef
  • Iodine status and its association with prevalence of thyroid diseases in adults from Jiangxi Province, China
    Di-en Yan, Lei Hu, Yun-feng Shen, Xiao-yang Lai, Mei-ying Zhang, Min Zhou, Chao Chen, Mei-mei Liu, Li-ting Wu, Li-qun Liu, Qi-wei Fan, Wen-lan Min, Si-cong Wan, Fang Zou, Jing Li, Xia Cai, Shui-hong Lei, Yan Xiong, Ya Yang, Rong Yu, Wei-wei Gao, Ying Zhan
    Endocrine.2023; 82(2): 335.     CrossRef
  • Autoimmune thyroid status in subclinical thyroid disorders in patients attending a tertiary care center in Nepal: a hospital-based cross-sectional study
    Vijay Kumar Sharma, Apeksha Niraula, Eans Tara Tuladhar, Aseem Bhattarai, Mithileshwer Raut, Raju Kumar Dubey, Sujata Baidya, Naresh Parajuli
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • INFLUÊNCIA DA NUTRIÇÃO NO MANEJO DO HIPOTIREOIDISMO
    Karine Rodrigues da Silva Neumann , Isadora Neres Silva, Elaine Cristina Rocha Oliveira, Taís Cristina Macêdo de Carvalho
    Revista Saúde Dos Vales.2023;[Epub]     CrossRef
  • Relationship between Thyroid CT Density, Volume, and Future TSH Elevation: A 5-Year Follow-Up Study
    Tomohiro Kikuchi, Shouhei Hanaoka, Takahiro Nakao, Yukihiro Nomura, Takeharu Yoshikawa, Md Ashraful Alam, Harushi Mori, Naoto Hayashi
    Life.2023; 13(12): 2303.     CrossRef
  • The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis
    Xueqi Zhang, Fan Zhang, Qiuxian Li, Renaguli Aihaiti, Chuyao Feng, Deshi Chen, Xu Zhao, Weiping Teng
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The impact of the micronutrient iodine in health and diseases
    Ma. Cecilia Opazo, Irenice Coronado-Arrázola, Omar P. Vallejos, Rodrigo Moreno-Reyes, Carlos Fardella, Lorena Mosso, Alexis M. Kalergis, Susan M. Bueno, Claudia A. Riedel
    Critical Reviews in Food Science and Nutrition.2022; 62(6): 1466.     CrossRef
  • Halogens in Seaweeds: Biological and Environmental Significance
    Hanan Al-Adilah, Martin C. Feiters, Lucy J. Carpenter, Puja Kumari, Carl J. Carrano, Dhia Al-Bader, Frithjof C. Küpper
    Phycology.2022; 2(1): 132.     CrossRef
  • Solid sorbents for gaseous iodine capture and their conversion into stable waste forms
    R. Pénélope, L. Campayo, M. Fournier, A. Gossard, A. Grandjean
    Journal of Nuclear Materials.2022; 563: 153635.     CrossRef
  • Secular Trends in the Prevalence of and Disability-Adjusted Life Years Due to Common Micronutrient Deficiencies in China From 1990 to 2019: An Age-Period-Cohort Study and Joinpoint Analysis
    Haiying Chen, Jinxin Lu, Yongze Li
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Iodine Concentrations in Conventional and Organic Milk in the Northeastern U.S.
    Nobumitsu Sakai, Ola Yetunde Esho, Motoko Mukai
    Dairy.2022; 3(2): 211.     CrossRef
  • Effect of iodine restriction on short-term changes in thyroid function in patients with subclinical hypothyroidism
    Obin Kwon, Dong Yeob Shin, Eun Jig Lee
    Journal of Nutrition and Health.2022; 55(2): 250.     CrossRef
  • Excessive iodine in iodized household salt in Nepal
    Basant Giri, Shishir Pandey, Sadiksha Shakya, Bhanu Bhakta Neupane, Krishna Prasad Kandel, Chandradip Kumar Yadav, Ram Prabodh Yadav, Bishnu Prasad Neupane, Rajendra Bahadur GC, Prem Singh Saud, Meghraj Yonjan
    Annals of the New York Academy of Sciences.2022; 1514(1): 166.     CrossRef
  • Factors associated with inadequate urinary iodine concentration among pregnant women in Mbeya region Tanzania.
    Tedson Lukindo, Ray Masumo, Adam Hancy, Sauli E. John, Heavenlight A. Paulo, Abraham Sanga, Ramadhan Noor, Fatoumata Lankoande, Elifatio Towo, Germana H. Leyna, Gemma Bridge, Raman Bedi
    F1000Research.2022; 10: 858.     CrossRef
  • Iodine nutrition and papillary thyroid cancer
    Xueqi Zhang, Fan Zhang, Qiuxian Li, Chuyao Feng, Weiping Teng
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Thyroid function disorders
    Mirjana Stojković
    Arhiv za farmaciju.2022; 72(5): 429.     CrossRef
  • Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease
    Yotsapon Thewjitcharoen, Krittadhee Karndumri, Waralee Chatchomchuan, Sriurai Porramatikul, Sirinate Krittiyawong, Ekgaluck Wanothayaroj, Siriwan Butadej, Soontaree Nakasatien, Rajata Rajatanavin, Thep Himathongkam
    Journal of the Endocrine Society.2021;[Epub]     CrossRef
  • Factors influencing the reference interval of thyroid‐stimulating hormone in healthy adults: A systematic review and meta‐analysis
    Dongyang Xing, Delong Liu, Ri Li, Qi Zhou, Jiancheng Xu
    Clinical Endocrinology.2021; 95(3): 378.     CrossRef
  • The Iodine Status and Prevalence of Thyroid Disorders Among Women of Childbearing Age in China: National Cross-sectional Study
    Yongze Li, Zhongyan Shan, Weiping Teng
    Endocrine Practice.2021; 27(10): 1028.     CrossRef
  • Environmental and human iodine and selenium status: lessons from Gilgit-Baltistan, North-East Pakistan
    Saeed Ahmad, Elizabeth H. Bailey, Muhammad Arshad, Sher Ahmed, Michael J. Watts, Alex G. Stewart, Scott D. Young
    Environmental Geochemistry and Health.2021; 43(11): 4665.     CrossRef
  • Factors associated with inadequate urinary iodine concentration among pregnant women in Mbeya region Tanzania.
    Tedson Lukindo, Ray Masumo, Adam Hancy, Sauli E. John, Heavenlight A. Paulo, Abraham Sanga, Ramadhan Noor, Fatoumata Lankoande, Elifatio Towo, Germana H. Leyna, Gemma Bridge, Raman Bedi
    F1000Research.2021; 10: 858.     CrossRef
  • Association between Iodine Intake, Thyroid Function, and Papillary Thyroid Cancer: A Case-Control Study
    Kyungsik Kim, Sun Wook Cho, Young Joo Park, Kyu Eun Lee, Dong-Wook Lee, Sue K. Park
    Endocrinology and Metabolism.2021; 36(4): 790.     CrossRef
  • Dietary Micronutrients from Zygote to Senility: Updated Review of Minerals’ Role and Orchestration in Human Nutrition throughout Life Cycle with Sex Differences
    Mohamed A. Farag, Samia Hamouda, Suzan Gomaa, Aishat A. Agboluaje, Mohamad Louai M. Hariri, Shimaa Mohammad Yousof
    Nutrients.2021; 13(11): 3740.     CrossRef
  • Епідеміологія автоімунного тиреоїдиту
    V.I. Кravchenko, О.А. Тоvkay, О.V. Rakov, М.D. Тronko
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(2): 136.     CrossRef
  • Association between urinary sodium levels and iodine status in Korea
    Jonghwa Ahn, Jang Ho Lee, Jiwoo Lee, Ji Yeon Baek, Eyun Song, Hye-Seon Oh, Mijin Kim, Suyeon Park, Min Ji Jeon, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Won Gu Kim
    The Korean Journal of Internal Medicine.2020; 35(2): 392.     CrossRef
  • Is heart disease a risk factor for low dementia test battery scores in older persons with Down syndrome? Exploratory, pilot study, and commentary
    Maire E. Percy, Walter J. Lukiw
    International Journal of Developmental Disabilities.2020; 66(1): 22.     CrossRef
  • A cross-sectional research of iodine status of pregnant women in Chongqing, south-west China
    Ning Yao, Chunbei Zhou, Jun Xie, Shuang Zhou
    Public Health Nutrition.2020; 23(5): 769.     CrossRef
  • The Diverse Upper Reference Limits of Serum Thyroid-Stimulating Hormone on the Same Platform for Pregnant Women in China
    Guocheng Wang, Guojun Zhang
    Laboratory Medicine.2020; 51(4): 416.     CrossRef
  • Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China
    Yongze Li, Di Teng, Jianming Ba, Bing Chen, Jianling Du, Lanjie He, Xiaoyang Lai, Xiaochun Teng, Xiaoguang Shi, Yanbo Li, Haiyi Chi, Eryuan Liao, Chao Liu, Libin Liu, Guijun Qin, Yingfen Qin, Huibiao Quan, Bingyin Shi, Hui Sun, Xulei Tang, Nanwei Tong, Gu
    Thyroid.2020; 30(4): 568.     CrossRef
  • High prevalence of TPO-Abs and subclinical hypothyroidism in iodine-sufficient pregnant women in Northern Algeria
    Samira Akdader-Oudahmane, Zohra Hamouli-Saïd, Michael B. Zimmermann, Hanane Kherrab, Said Azzoug, Djamila Meskine
    Journal of Trace Elements in Medicine and Biology.2020; 61: 126533.     CrossRef
  • An Inverse Relationship Between Iodine Intake and Thyroid Antibodies: A National Cross-Sectional Survey in Mainland China
    Di Teng, Wenqing Yang, Xiaoguang Shi, Yongze Li, Jianming Ba, Bing Chen, Jianling Du, Lanjie He, Xiaoyang Lai, Yanbo Li, Haiyi Chi, Eryuan Liao, Chao Liu, Libin Liu, Guijun Qin, Yingfen Qin, Huibiao Quan, Bingyin Shi, Hui Sun, Xulei Tang, Nanwei Tong, Gui
    Thyroid.2020; 30(11): 1656.     CrossRef
  • Therapeutic Effects of Combination Regimens Including Methimazole on Graves Hyperthyroidism: A Network Meta-Analysis of Randomized Controlled Trials
    Maorong Wang, Yerong Yu
    Endocrine Practice.2020; 26(6): 675.     CrossRef
  • The change in the clinical presentation of Graves’ disease: a 30 years retrospective survey in an academic Brazilian tertiary center
    Wanesa Pinto, João H. Romaldini, Nicolas Perini, Roberto B. Santos, Danilo Villagelin
    Archives of Endocrinology and Metabolism.2020;[Epub]     CrossRef
  • Association between Urinary Iodine Concentration and Thyroid Nodules in Adults: A Cross-Sectional Study in China
    Hui Sun, Hanyu Wang, Xiaolan Lian, Chao Liu, Bingyin Shi, Lixin Shi, Nanwei Tong, Shu Wang, Jianping Weng, Jiajun Zhao, Jiaoyue Zhang, Juan Zheng, Xiang Hu, Yunxia Tu, Li Yu, Zhongyan Shan, Weiping Teng, Lulu Chen, Ali Abbara
    BioMed Research International.2020; 2020: 1.     CrossRef
  • The effect of intake of sausages fortified with β-CD-I2 complex on iodine status and thyroid function: A preliminary study
    Maksym Polumbryk, Victor Kravchenko, Vasyl Pasichnyi, Chrystyna Omelchenko, Irina Pachitskaya
    Journal of Trace Elements in Medicine and Biology.2019; 51: 159.     CrossRef
  • Association between Iodine Nutrition Status and Thyroid Disease-Related Hormone in Korean Adults: Korean National Health and Nutrition Examination Survey VI (2013–2015)
    Sohye Kim, Yong Seok Kwon, Ju Young Kim, Kyung Hee Hong, Yoo Kyoung Park
    Nutrients.2019; 11(11): 2757.     CrossRef
  • Association Between Thyroid Nodules and Volume and Metabolic Syndrome in an Iodine-Adequate Area: A Large Community-Based Population Study
    Yue Su, Yan-ling Zhang, Meng Zhao, Hai-qing Zhang, Xu Zhang, Qing-bo Guan, Chun-xiao Yu, Shan-shan Shao, Jin Xu
    Metabolic Syndrome and Related Disorders.2019; 17(4): 217.     CrossRef
  • Analytical evaluation of the new Seal Autoanalyzer 3 High Resolution for urinary iodine determination
    Valentina Vidranski, Maja Franceschi, Dražena Krilić, Tomislav Jukić, Ivan Mihaljević, Zvonko Kusić
    Biochemia medica.2019; 29(2): 394.     CrossRef
  • Increased Incidence Rate of Hypothyroidism After Iodine Fortification in Denmark: A 20-Year Prospective Population-Based Study
    Mads Petersen, Nils Knudsen, Allan Carlé, Stig Andersen, Torben Jørgensen, Hans Perrild, Lars Ovesen, Lone Banke Rasmussen, Betina Heinsbæk Thuesen, Inge Bülow Pedersen
    The Journal of Clinical Endocrinology & Metabolism.2019; 104(5): 1833.     CrossRef
  • Relationship of gender and age on thyroid hormone parameters in a large Chinese population
    Xinxin Chen, Xulei Zheng, Zhaojun Ding, Yang Su, Shu Wang, Bin Cui, Zhen Xie
    Archives of Endocrinology and Metabolism.2019;[Epub]     CrossRef
  • Sex differences in the association between thyroid-stimulating hormone levels and depressive symptoms among the general population with normal free T4 levels
    San Lee, Sarah Soyeon Oh, Eun-Cheol Park, Sung-In Jang
    Journal of Affective Disorders.2019; 249: 151.     CrossRef
  • Reference intervals of thyroid hormones in a previously iodine-deficient area in Darfur, Sudan
    Nagi I. Ali, Abdullah O. Alamoudi, Ishag Adam
    Therapeutic Advances in Endocrinology and Metabolism.2018; 9(9): 293.     CrossRef
  • Highly sensitive electrochemical detection of iodate based on glassy carbon electrode modified with iridium oxide
    Yanna Lazarova, Ivan Shterev, Totka Dodevska
    Monatshefte für Chemie - Chemical Monthly.2018; 149(11): 1955.     CrossRef
  • Acute Delirium in a Hypothyroid Patient Precipitated by Iodine Supplements Use
    Gaby S. Gil, Bradford W. Smith, Jose R. Guerra, William T. Williams
    American Journal of Therapeutics.2018; 25(6): e717.     CrossRef
  • Iodine Deficiency in Zhejiang Pregnant Women in the Context of Universal Salt Iodization Programme
    Zhifang Wang, Mingluan Xing, Wenming Zhu, Guangming Mao, Zhe Mo, Yuanyang Wang, Zhijian Chen, Xiaoming Lou, Shichang Xia, Xiaofeng Wang
    Scientific Reports.2018;[Epub]     CrossRef
  • Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013–2015)
    So Young Park, Hae In Kim, Hyun-Kyung Oh, Tae Hyuk Kim, Hye Won Jang, Jae Hoon Chung, Myung-Hee Shin, Sun Wook Kim, Sun Y Lee
    PLOS ONE.2018; 13(2): e0190738.     CrossRef
  • Age-specific reference interval of serum TSH levels is high in adolescence in an iodine excess area: Korea national health and nutrition examination survey data
    Hyemi Kwon, Won Gu Kim, Min Ji Jeon, Minkyu Han, Mijin Kim, Suyeon Park, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Endocrine.2017; 57(3): 445.     CrossRef
  • Urinary iodine levels and dairy consumption in pre-school children in Southwest Asturias (Spain)
    Esther Arbesú Fernández, María Haydee Serrano Peraza, Hans Abdón Eguia Angeles, César Oliver Sotelo García, Claude Henrry Saint Jean, Nache Ismael Musa Martín
    Anales de Pediatría (English Edition).2017; 87(1): 18.     CrossRef
  • Association of iodized salt with goiter prevalence in Chinese populations: a continuity analysis over time
    Zhen Liang, Chen Xu, Yong-Jun Luo
    Military Medical Research.2017;[Epub]     CrossRef
  • Yodurias y consumo de lácteos en preescolares del Área Suroccidental de Asturias
    Esther Arbesú Fernández, M. Haydee Serrano Peraza, Hans Abdón Eguia Angeles, César Oliver Sotelo García, Claude Henrry Saint Jean, Nache Ismael Musa Martín
    Anales de Pediatría.2017; 87(1): 18.     CrossRef
  • Role of medical resource level in iodine deficiency disorder
    Chen Xu, Zhen Liang, Yong-Jun Luo
    Military Medical Research.2017;[Epub]     CrossRef
  • Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area
    Hye Jeong Kim, Na Kyung Kim, Hyeong Kyu Park, Dong Won Byun, Kyoil Suh, Myung Hi Yoo, Yong-Ki Min, Sun Wook Kim, Jae Hoon Chung
    European Journal of Nutrition.2017; 56(3): 965.     CrossRef
  • Excessive Iodine Intake and Thyrotropin Reference Interval: Data from the Korean National Health and Nutrition Examination Survey
    Min Ji Jeon, Won Gu Kim, Hyemi Kwon, Mijin Kim, Suyeon Park, Hye-Seon Oh, Minkyu Han, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Thyroid.2017; 27(7): 967.     CrossRef
  • Metabolic syndrome is associated with an increased incidence of subclinical hypothyroidism – A Cohort Study
    Chia-Hsuin Chang, Yi-Chun Yeh, James L. Caffrey, Shyang-Rong Shih, Lee-Ming Chuang, Yu-Kang Tu
    Scientific Reports.2017;[Epub]     CrossRef
  • Associations between thyroid dysfunction and developmental status in children with excessive iodine status
    Inger Aakre, Tor A. Strand, Khalil Moubarek, Ingrid Barikmo, Sigrun Henjum, Hiroyoshi Ariga
    PLOS ONE.2017; 12(11): e0187241.     CrossRef
  • Vitamin D deficiency affects thyroid autoimmunity and dysfunction in iodine-replete area: Korea national health and nutrition examination survey
    Mijin Kim, Eyun Song, Hye-Seon Oh, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Won Gu Kim, Won Bae Kim, Young Kee Shong, Tae Yong Kim
    Endocrine.2017; 58(2): 332.     CrossRef
  • Thyroid Function Status in Indian Adult Nonpregnant Females in Ranchi, India
    Nandita Hazra, Sarvinder Singh, Binay Mitra, Bhaskar Shahbabu
    Indian journal of Medical Biochemistry.2017; 21(1): 25.     CrossRef
  • Iodine Status and Prevalence of Thyroid Disorders After Introduction of Mandatory Universal Salt Iodization for 16 Years in China: A Cross-Sectional Study in 10 Cities
    Zhongyan Shan, Lulu Chen, Xiaolan Lian, Chao Liu, Bingyin Shi, Lixin Shi, Nanwei Tong, Shu Wang, Jianping Weng, Jiajun Zhao, Xiaochun Teng, Xiaohui Yu, Yaxin Lai, Weiwei Wang, Chenyan Li, Jinyuan Mao, Yongze Li, Chenling Fan, Weiping Teng
    Thyroid.2016; 26(8): 1125.     CrossRef
  • Iodine nutrition status and thyroid disorders: a cross-sectional study from the Xinjiang Autonomous Region of China
    Y Guo, J Zynat, Z Xu, X Wang, R Osiman, H Zhao, A Tuhuti, M Abdunaimu, H Wang, X Jin, S Xing
    European Journal of Clinical Nutrition.2016; 70(11): 1332.     CrossRef
  • Effect of Prolonged Iodine Overdose on Type 2 Iodothyronine Deiodinase Ubiquitination-Related Enzymes in the Rat Pituitary
    Xiaowen Zhang, Yaqiu Jiang, Wenqing Han, Aihua Liu, Xiaochen Xie, Cheng Han, Chenling Fan, Hong Wang, Hongmei Zhang, Shuangning Ding, Zhongyan Shan, Weiping Teng
    Biological Trace Element Research.2016; 174(2): 377.     CrossRef
  • Reference intervals of thyroid hormones in a previously iodine-deficient but presently more than adequate area of Western China: a population-based survey
    Jing Cai, Yujie Fang, Da Jing, Shaoyong Xu, Jie Ming, Bin Gao, Han Shen, Rong Zhang, Qiuhe Ji
    Endocrine Journal.2016; 63(4): 381.     CrossRef
  • Urinary Iodine Excretion among Nepalese School Children in Terai Region
    Saroj Khatiwada, Basanta Gelal, Prem Raj Shakya, Madhab Lamsal, Nirmal Baral
    The Indian Journal of Pediatrics.2016; 83(1): 15.     CrossRef
  • Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease
    Hyemi Kwon, Won Gu Kim, Eun Kyung Jang, Mijin Kim, Suyeon Park, Min Ji Jeon, Tae Yong Kim, Jin-Sook Ryu, Young Kee Shong, Won Bae Kim
    Endocrinology and Metabolism.2016; 31(2): 300.     CrossRef
  • Evaluation of energy spectrum CT for the measurement of thyroid iodine content
    Weiguang Shao, Jingang Liu, Dianmei Liu
    BMC Medical Imaging.2016;[Epub]     CrossRef
  • Iodide Residues in Milk Vary between Iodine‐Based Teat Disinfectants
    Elizabeth A. French, Motoko Mukai, Michael Zurakowski, Bradley Rauch, Gloria Gioia, Joseph R. Hillebrandt, Mark Henderson, Ynte H. Schukken, Thomas C. Hemling
    Journal of Food Science.2016;[Epub]     CrossRef
  • Total thyroidectomy as primary surgical management for thyroid disease: surgical therapy experience from 5559 thyroidectomies in a less-developed region
    Jisheng Hu, Nan Zhao, Rui Kong, Dawei Wang, Bei Sun, Lifeng Wu
    World Journal of Surgical Oncology.2015;[Epub]     CrossRef
  • Tg in Adults as a Sensitive Biomarker of Iodine Status: A 5-Year Follow up Population Study in Different Levels of Iodine Intake Regions
    Wei Chong, Xiaoguang Shi, Zhongyan Shan, Xiaochun Teng, Di Teng, Haixia Guan, Yushu Li, Ying Jin, Xiaohui Yu, Chenling Fan, Fan Yang, Hong Dai, Yang Yu, Jia Li, Yanyan Chen, Dong Zhao, Fengnan Hu, Jinyuan Mao, Xiaolan Gu, Rong Yang, Yajie Tong, Weibo Wang
    PLOS ONE.2015; 10(8): e0135553.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer
Editorials
Thyroid
Cost-of-Illness Trend of Thyroid Gland Disease in Korea
Jae Hoon Chung
Endocrinol Metab. 2014;29(3):248-250.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.248
  • 3,396 View
  • 26 Download
  • 1 Web of Science
  • 2 Crossref
PDFPubReader   

Citations

Citations to this article as recorded by  
  • Overdiagnosis of papillary carcinoma — who benefits?
    Juan P. Brito, Ian D. Hay
    Nature Reviews Endocrinology.2017; 13(3): 131.     CrossRef
  • Clinical characteristics and outcome of cancer diagnosed during pregnancy
    Min Hee Shim, Chi-Won Mok, Kylie Hae-Jin Chang, Ji-Hee Sung, Suk-Joo Choi, Soo-young Oh, Cheong-Rae Roh, Jong-Hwa Kim
    Obstetrics & Gynecology Science.2016; 59(1): 1.     CrossRef
Close layer
Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
Won-Young Lee
Endocrinol Metab. 2014;29(3):251-256.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.251
  • 3,218 View
  • 26 Download
PDFPubReader   
Close layer
Original Articles
Thyroid
Cost-of-Illness Trends Associated with Thyroid Disease in Korea
Kyung-Rae Hyun, Sungwook Kang, Sunmi Lee
Endocrinol Metab. 2014;29(3):257-269.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.257
  • 4,661 View
  • 30 Download
  • 11 Web of Science
  • 9 Crossref
AbstractAbstract PDFPubReader   
Background

The purpose of this study is to analyze the scale of and trends associated with the cost-of-illness of thyroid disease in Korea at 2-year intervals during the last 10 years for which data are available.

Methods

Cost-of-illness was estimated in terms of direct and indirect costs. Direct costs include direct medical costs due to hospitalization, outpatient and pharmacy sectors, transportation, and care-giver costs. Indirect costs include future income loss due to premature death and loss of productivity as a result of absence from work.

Results

The cost-of-illness of thyroid disease in Korea was estimated at 224.2 billion won in 2002, 303.4 billion won in 2004, 400.3 billion won in 2006, 570.4 billion won in 2008, and 762.2 billion won in 2010. For example, the cost-of-illness of thyroid disease in 2010 was 3.4 times greater compared to 2002. The direct cost of the total cost-of-illness was 69.7%, which accounted for the highest proportion of costs. Cost-of-illness for individuals between the ages of 30 and 50 accounted for the greatest share of costs.

Conclusion

The cost-of-illness of thyroid disease was relatively large in economically active age groups, and demonstrated a very rapid growth rate compared to other major diseases in Korea. Therefore, we suggest nationwide recognition of the importance of prevention and management of thyroid disease and prioritization of the management of thyroid disease among current and future health promotion policies in Korea.

Citations

Citations to this article as recorded by  
  • Clinical Impact of Obesity on Postoperative Outcomes of Patients With Thyroid Cancer Undergoing Thyroidectomy: A 5‐Year Retrospective Analysis From the US National Inpatient Sample
    Yue Chen, Jiewen Jin, Pengyuan Zhang, Runyi Ye, Chuimian Zeng, Yilin Zhang, Junxin Chen, Hai Li, Haipeng Xiao, Yanbing Li, Hongyu Guan
    Cancer Medicine.2024;[Epub]     CrossRef
  • Cancer and Mortality Risks of Graves’ Disease in South Korea Based on National Data from 2010 to 2019
    Young Ju Choi, Kyungdo Han, Won Kyoung Cho, Min Ho Jung, Byung-Kyu Suh
    Clinical Epidemiology.2023; Volume 15: 535.     CrossRef
  • Who loses more? Identifying the relationship between hospitalization and income loss: prediction of hospitalization duration and differences of gender and employment status
    Minsung Sohn, Daseul Moon, Patricia O’Campo, Carles Muntaner, Haejoo Chung
    BMC Public Health.2022;[Epub]     CrossRef
  • The importance and effectiveness of nutritional counselling in patients with autoimmune thyroid diseases in Poland
    Ewa Czubek, Klaudia Alcer, Mirjana Varjacic, Piotr Romaniuk
    Cost Effectiveness and Resource Allocation.2022;[Epub]     CrossRef
  • Socioeconomic Costs of Dementia Based on Utilization of Health Care and Long-Term-Care Services: A Retrospective Cohort Study
    Eun-Jeong Han, JungSuk Lee, Eunhee Cho, Hyejin Kim
    International Journal of Environmental Research and Public Health.2021; 18(2): 376.     CrossRef
  • Triennial Report ofEndocrinology and Metabolism, 2015 to 2017
    Eun-Jung Rhee, Hey Yeon Jang, Won-Young Lee
    Endocrinology and Metabolism.2018; 33(2): 195.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Cost-of-Illness Trend of Thyroid Gland Disease in Korea
    Jae Hoon Chung
    Endocrinology and Metabolism.2014; 29(3): 248.     CrossRef
  • Letter: Insufficient Experience in Thyroid Fine-Needle Aspiration Leads to Misdiagnosis of Thyroid Cancer (Endocrinol Metab2014;29:293-9, Jung Il Son et al.)
    Hyon-Seung Yi, Sihoon Lee
    Endocrinology and Metabolism.2014; 29(4): 590.     CrossRef
Close layer
Genetic and Epigenetic Analysis in Korean Patients with Multiple Endocrine Neoplasia Type 1
Yoon Jung Chung, Sena Hwang, Jong Ju Jeong, Sun Yong Song, Se Hoon Kim, Yumie Rhee
Endocrinol Metab. 2014;29(3):270-279.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.270
  • 4,269 View
  • 50 Download
  • 3 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   
Background

Multiple endocrine neoplasia type 1 (MEN1) is a familial syndrome characterized by the parathyroid, pancreas and pituitary tumors. Parathyroid tumors are the most common clinical manifestations, occurring in more than 90% of MEN1 patients. Heterozygous germline mutations of the MENIN gene underlie the tumorigenesis in MEN1 and epigenetic alterations along with germline mutations may contribute to tumorigenesis. Here, we investigated the associations between genotype and phenotype in Korean MEN1 patients.

Methods

We analyzed medical records from 14 unrelated MEN1 patients who had newly confirmed MENIN germline mutations, together with 14 previous reports in Korea. Aberrant DNA methylations were also examined in MEN1-related parathyroid tumors using the Infinium HumanMethylation 450 BeadChip.

Results

Total 28 germline mutations of MENIN were relatively highly concentrated in exons 7 and 8 compared to previous reports from Western countries. Six mutations (c.111dupT/p.S38Ffs*79, c.225_226insT/p.T76Yfs*41, c.383_398del16/p.S128Tfs*52, c.746dupT/p.H250Afs*20, c.1150G>T/p.E384*, and c.1508G>A/p.G503N) were newly found in the present study. Of interest, four patients (15%) showed unusual initial presentations and three patients were diagnosed incidentally at the general medical checkup. We also found three distinct sites in exon 2 of MENIN were significantly hypomethylated in the MEN1 parathyroid tumors, comparing correspondent blood samples.

Conclusion

We also have found a lack of genotype/phenotype correlation in Korean MEN1 patients. There were not a few unusual initial manifestations in MEN1 patients, thus, genetic testing for the MENIN germline mutations can provide important information for the better prognosis. Further studies are warranted to investigate altered DNA methylations in the MENIN gene involved in tumorigenesis.

Citations

Citations to this article as recorded by  
  • Genotype-based prognosis prediction for MEN1-Related pancreatic neuroendocrine tumors in Korean patients a single-center retrospective study
    Juwan Kim, Seung Soo Hong, Sung Hyun Kim, Ho Kyoung Hwang, Namki Hong, Yumie Rhee, Chang Moo Kang
    Pancreatology.2024;[Epub]     CrossRef
  • Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome
    Laura Pierotti, Elena Pardi, Elisa Dinoi, Paolo Piaggi, Simona Borsari, Simone Della Valentina, Chiara Sardella, Angela Michelucci, Maria Adelaide Caligo, Fausto Bogazzi, Claudio Marcocci, Filomena Cetani
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • A Case of Asymptomatic Multiple Endocrine Neoplasia Type I with Thymic Carcinoid
    Suk Ki Park, Moon Won Lee, In Sub Han, Young Joo Park, Sung Yong Han, Joon Woo Park, Bong Eun Lee, Gwang Ha Kim, Sang Soo Kim
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2019; 19(1): 65.     CrossRef
  • Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives
    Fatemeh Khatami, Seyed Mohammad Tavangar
    Biomarker Insights.2018;[Epub]     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer
Adrenal gland
Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
Youngki Lee, Cheol Ryong Ku, Eui-Hyun Kim, Jae Won Hong, Eun Jig Lee, Sun Ho Kim
Endocrinol Metab. 2014;29(3):280-292.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.280
  • 5,192 View
  • 61 Download
  • 15 Web of Science
  • 16 Crossref
AbstractAbstract PDFPubReader   
Background

Cabergoline is typically effective for treating prolactinomas; however, some patients display cabergoline resistance, and the early characteristics of these patients remain unclear. We analyzed early indicators predicting long-term response to cabergoline.

Methods

We retrospectively reviewed the cases of 44 patients with macroprolactinomas who received cabergoline as first-line treatment; the patients were followed for a median of 16 months. The influence of various clinical parameters on outcomes was evaluated.

Results

Forty patients (90.9%) were treated medically and displayed tumor volume reduction (TVR) of 74.7%, a prolactin normalization (NP) rate of 81.8%, and a complete response (CR; TVR >50% with NP, without surgery) rate of 70.5%. Most patients (93.1%) with TVR ≥25% and NP at 3 months eventually achieved CR, whereas only 50% of patients with TVR ≥25% without NP and no patients with TVR <25% achieved CR. TVR at 3 months was strongly correlated with final TVR (R=0.785). Patients with large macroadenomas exhibited a low NP rate at 3 months, but eventually achieved TVR and NP rates similar to those of patients with smaller tumors. Surgery independently reduced the final dose of cabergoline (β=-1.181 mg/week), and two of four patients who underwent surgery were able to discontinue cabergoline.

Conclusion

Determining cabergoline response using TVR and NP 3 months after treatment is useful for predicting later outcomes. However, further cabergoline administration should be considered for patients with TVR >25% at 3 months without NP, particularly those with huge prolactinomas, because a delayed response may be achieved. As surgery can reduce the cabergoline dose necessary for successful disease control, it should be considered for cabergoline-resistant patients.

Citations

Citations to this article as recorded by  
  • Resistance to dopamine agonists in the treatment of prolactinomas: diagnostic criteria, mechanisms and ways to overcome it
    Irena A. Ilovayskaya, Gulnar R. Vagapova
    Almanac of Clinical Medicine.2024; 51(7): 397.     CrossRef
  • Medical treatment of functional pituitary adenomas, trials and tribulations
    Cristina Capatina, Felicia Alexandra Hanzu, José Miguel Hinojosa-Amaya, Maria Fleseriu
    Journal of Neuro-Oncology.2024; 168(2): 197.     CrossRef
  • Feasibility of Early Surgical Treatment for Adolescent Patients with Prolactinoma: A Case Report and Literature Review
    Yu-Hung Tsai, Chi-Ruei Li, Yu-Ting Wang, Se-Yi Chen
    Medicina.2024; 60(8): 1345.     CrossRef
  • Noninvasive radiomics approach predicts dopamine agonists treatment response in patients with prolactinoma: a multicenter study
    Yanghua Fan, Shuaiwei Guo, Chuming Tao, Hua Fang, Anna Mou, Ming Feng, Zhen Wu
    Academic Radiology.2024;[Epub]     CrossRef
  • Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement
    Stephan Petersenn, Maria Fleseriu, Felipe F. Casanueva, Andrea Giustina, Nienke Biermasz, Beverly M. K. Biller, Marcello Bronstein, Philippe Chanson, Hidenori Fukuoka, Monica Gadelha, Yona Greenman, Mark Gurnell, Ken K. Y. Ho, Jürgen Honegger, Adriana G.
    Nature Reviews Endocrinology.2023; 19(12): 722.     CrossRef
  • Outcome Measures for Medical and Surgical Treatment of Prolactinomas. Is the Role of Surgery Underestimated?
    Andrius Anuzis, Kevin O. Lillehei
    Journal of Neurological Surgery Part B: Skull Base.2023;[Epub]     CrossRef
  • Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis
    Xiangming Cai, Junhao Zhu, Jin Yang, Chao Tang, Zixiang Cong, Chiyuan Ma
    Chinese Neurosurgical Journal.2022;[Epub]     CrossRef
  • Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors
    Renato Cozzi, Maria Rosaria Ambrosio, Roberto Attanasio, Claudia Battista, Alessandro Bozzao, Marco Caputo, Enrica Ciccarelli, Laura De Marinis, Ernesto De Menis, Marco Faustini Fustini, Franco Grimaldi, Andrea Lania, Giovanni Lasio, Francesco Logoluso, M
    European Journal of Endocrinology.2022; 186(3): P1.     CrossRef
  • Biochemical Remission after Cabergoline Withdrawal in Hyperprolactinemic Patients with Visible Remnant Pituitary Adenoma
    Kyungwon Kim, Yae Won Park, Daham Kim, Sung Soo Ahn, Ju Hyung Moon, Eui Hyun Kim, Eun Jig Lee, Cheol Ryong Ku
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(2): e615.     CrossRef
  • Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas
    Ji Yong Park, Wonsuk Choi, A Ram Hong, Jee Hee Yoon, Hee Kyung Kim, Woo-Youl Jang, Shin Jung, Ho-Cheol Kang
    Pituitary.2021; 24(6): 955.     CrossRef
  • Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications
    Betina Biagetti, Rafael Simò
    International Journal of Molecular Sciences.2021; 22(20): 11247.     CrossRef
  • A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas
    Rakesh Mishra, Subhas K. Konar, Adesh Shrivastava, Pradeep Chouksey, Sumit Raj, Amit Agrawal
    Indian Journal of Endocrinology and Metabolism.2021; 25(6): 493.     CrossRef
  • Predictors of dopamine agonist resistance in prolactinoma patients
    Elle Vermeulen, Jean D’Haens, Tadeusz Stadnik, David Unuane, Kurt Barbe, Vera Van Velthoven, Sven Gläsker
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • The Role of Dopamine Agonists in Pituitary Adenomas
    Erica A. Giraldi, Adriana G. Ioachimescu
    Endocrinology and Metabolism Clinics of North America.2020; 49(3): 453.     CrossRef
  • Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
    Daham Kim, Yongin Cho, Cheol Ryong Ku, Hyein Jung, Ju Hyung Moon, Eui Hyun Kim, Dong Yeob Shin, Sun Ho Kim, Eun Jig Lee
    Journal of Clinical Medicine.2019; 8(8): 1142.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer
Thyroid
Insufficient Experience in Thyroid Fine-Needle Aspiration Leads to Misdiagnosis of Thyroid Cancer
Jung Il Son, Sang Youl Rhee, Jeong-taek Woo, Won Seo Park, Jong Kyu Byun, Yu-Jin Kim, Ja Min Byun, Sang Ouk Chin, Suk Chon, Seungjoon Oh, Sung Woon Kim, Young Seol Kim
Endocrinol Metab. 2014;29(3):293-299.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.293
  • 4,975 View
  • 36 Download
  • 13 Web of Science
  • 11 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   
Background

Fine-needle aspiration (FNA) of the thyroid is a widely accepted confirmatory test for thyroid cancer with high sensitivity and specificity. FNA is a simple procedure that is learned by many clinicians to enable accurate diagnosis of thyroid cancer. However, it is assumed that because the FNA test is a relatively simple procedure, its cytologic results are reliable regardless of the operator's experience. The aim of this study was to evaluate the differences in the diagnostic indices of FNA between operators with different levels of experience.

Methods

A total of 694 thyroid FNA specimens from 469 patients were reviewed, and were separated based on the experience of the clinicians who performed the procedure. One hundred and ninety were categorized in the experienced group, and 504 in the inexperienced group. All FNA results were then compared with histological data from surgically resected specimens, and the sample adequacy and diagnostic accuracy of the groups were compared.

Results

The age, gender, and nodule size and characteristics were similar in both groups. The sample adequacy rate was not significantly different between the experienced and nonexperienced groups (96.3% vs. 95.4%, P=0.682). However, the non-experienced group had a higher false-negative rate than the experienced group (6.4% vs. 17.2%, P=0.038), and the sensitivity of the FNA test also tended to be lower in the nonexperienced group (95.6% vs. 88.9%, P=0.065).

Conclusion

These results suggest that FNA operators who have less experience may miss cases of thyroid cancer by performing the procedure incorrectly. As such, the experience of the FNA operator should be considered when diagnosing thyroid cancer. When clinicians are being trained in FNA, more effort should be made to increase the accuracy of the procedure; therefore, enhanced teaching programs and/or a more detailed feedback system are recommended.

Citations

Citations to this article as recorded by  
  • The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma
    Zhenshengnan Li, Jia Wei, Bowen Chen, Yaoqi Wang, Shuai Yang, Kehui Wu, Xianying Meng
    Molecules.2023; 28(9): 3705.     CrossRef
  • Telecytology rapid onsite evaluation, with real-time communication between cytopathologist, cytotechnologist, and proceduralist, offers better adequacy rates for lymph node, but not thyroid, fine-needle aspirations
    Robert Post, Kelly Doxzon, Allison Goldberg
    Journal of the American Society of Cytopathology.2023; 12(6): 407.     CrossRef
  • Needle Biopsy Adequacy in the Era of Precision Medicine and Value-Based Health Care
    Kenneth P. H. Pritzker, Heikki J. Nieminen
    Archives of Pathology & Laboratory Medicine.2019; 143(11): 1399.     CrossRef
  • The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation
    Galina Chernaya, Nina Mikhno, Tatiana Khabalova, Svetlana Svyatchenko, Lyudmila Mostovich, Sergey Shevchenko, Lyudmila Gulyaeva
    Surgical Oncology.2018; 27(4): 702.     CrossRef
  • Can thyroid surgery be decided based on ultrasonographic findings, irrespective of cytopathological findings? Five-year retrospective study in a district general hospital
    A.A. Elsayed, C. Murdoch, S. Murray, K. Bashir
    Clinical Radiology.2017; 72(2): 170.     CrossRef
  • Efficacy of ultrasound‐guided fine‐needle aspiration performed by surgeons newly trained in thyroid ultrasound
    Agnaldo J. Graciano, Carlos A. Fischer, Carlos T. Chone, Giuliano S. Bublitz, Marina Sonagli, Cezar A. Rodrigues Filho
    Head & Neck.2017; 39(3): 439.     CrossRef
  • Usefulness of NRAS codon 61 mutation analysis and core needle biopsy for the diagnosis of thyroid nodules previously diagnosed as atypia of undetermined significance
    Eun Kyung Jang, Won Gu Kim, Eui Young Kim, Hyemi Kwon, Yun Mi Choi, Min Ji Jeon, Jung Hwan Baek, Jeong Hyun Lee, Tae Yong Kim, Young Kee Shong, Jene Choi, Dong Eun Song, Won Bae Kim
    Endocrine.2016; 52(2): 305.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Carcinosarcoma of the Thyroid Gland
    Mehmet Fatih Ekici, Cengiz Kocak, Zülfü Bayhan, Sezgin Zeren, Faik Yaylak, Mehmet Hüseyin Metineren, Fatma Emel Kocak
    Case Reports in Surgery.2015; 2015: 1.     CrossRef
  • Letter: Insufficient Experience in Thyroid Fine-Needle Aspiration Leads to Misdiagnosis of Thyroid Cancer (Endocrinol Metab2014;29:293-9, Jung Il Son et al.)
    Hyon-Seung Yi, Sihoon Lee
    Endocrinology and Metabolism.2014; 29(4): 590.     CrossRef
  • Response: Insufficient Experience in Thyroid Fine-Needle Aspiration Leads to Misdiagnosis of Thyroid Cancer (Endocrinol Metab2014;29:293-9, Jung Il Son et al.)
    Jung Il Son, Jeong-taek Woo
    Endocrinology and Metabolism.2014; 29(4): 592.     CrossRef
Close layer
Obesity and Metabolism
Testosterone Deficiency Associated with Poor Glycemic Control in Korean Male Diabetics
Joo-Sung Kim, Bong Sun Kim, Ja Young Jeon, Yong Jun Choi, Yoon-Sok Chung
Endocrinol Metab. 2014;29(3):300-306.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.300
  • 4,416 View
  • 33 Download
  • 9 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   
Background

Recent studies have shown that men with diabetes have lower testosterone levels than healthy men. However, studies on the correlation between testosterone and diabetes are rare in Korea. We examined the relationship between testosterone deficiency and markers related to diabetes in adult Korean men.

Methods

A total 464 men with diabetes who visited an outpatient clinic at Ajou University Hospital and had serum total testosterone and serum insulin levels measured between January 2000 and September 2013 were selected. Blood samples were collected after the subjects had fasted overnight. We divided the participants into testosterone deficient and normal groups. Testosterone deficiency was defined as having a serum total testosterone level <3.5 ng/mL.

Results

Of 464 subjects, 34.9% had a testosterone deficiency. The mean levels of fasting plasma glucose (P=0.007) and glycated hemoglobin (HbA1c; P=0.038) were significantly higher in the testosterone deficiency group than in the normal group. To clarify the relationship between serum total testosterone level and fasting plasma glucose or HbA1c values, Pearson's correlation test was performed. Fasting plasma glucose levels (r=-0.142, P=0.002) and HbA1c values (r=-0.097, P=0.040) showed a significant negative correlation with serum testosterone levels in men with diabetes.

Conclusion

Major markers of diabetes that are associated with testosterone deficiency are fasting plasma glucose and HbA1c values. Poor glycemic control appears to be associated with testosterone deficiency in Korean men with diabetes.

Citations

Citations to this article as recorded by  
  • Diabetes surpasses obesity as a risk factor for low serum testosterone level
    Samir H. Assaad Khalil, Paresh Dandona, Nermin A. Osman, Ramy Samir Assaad, Basma Tayseer Abdalla Zaitoon, Amal Abdulaziz Almas, Noha Gaber Amin
    Diabetology & Metabolic Syndrome.2024;[Epub]     CrossRef
  • Association between T2DM and the lowering of testosterone levels among Kashmiri males
    Rabia Farooq, Mohammad Hayat Bhat, Sabhiya Majid, Mohammad Muzaffar Mir
    Archives of Endocrinology and Metabolism.2020;[Epub]     CrossRef
  • Hypogonadism and associated risk factors in male patients with type 2 diabetes mellitus attending the diabetic clinic of Tikur Anbessa Specialized Teaching Hospital, Addis Ababa, Ethiopia
    Sisay Teka, Samuel Kinde, Gobena Dedefo, Kissi Mudi, Getahun Tarekegn
    Journal of Endocrinology, Metabolism and Diabetes of South Africa.2019; 24(1): 16.     CrossRef
  • Hypogonadism in Nigerian men with type 2 diabetes mellitus
    S. I. Onung, E. E. Young, T. E. Ugwu, O. A. Fasanmade
    International Journal of Diabetes in Developing Countries.2017; 37(3): 254.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer
Thyroid
The Association between Cobalt Deficiency and Endemic Goiter in School-Aged Children
Mojgan Sanjari, Ahmad Gholamhoseinian, Akram Nakhaee
Endocrinol Metab. 2014;29(3):307-311.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.307
  • 4,680 View
  • 41 Download
  • 7 Web of Science
  • 8 Crossref
AbstractAbstract PDFPubReader   
Background

In Iran, an iodine deficiency control program was initiated in 1989 by iodizing salt. Despite this program, goiters have remained an endemic condition in most parts of Iran. Thus, it is possible that other factors aside from iodine deficiency may contribute to endemic goiter. The aim of this study was to investigate the association between cobalt deficiency and endemic goiter in a region of Iran with a high prevalence of goiter.

Methods

A cross-sectional study was conducted among school children aged 9 to 11 years in the city of Kerman, Iran. In the first phase of the study, a multistage, proportional-to-size, cluster sampling method was used to screen 5,380 out of 29,787 students. After the screening phase, 170 students (130 goitrous and 40 nongoitrous) were randomly selected, and serum and urine specimens were obtained. We measured thyroid function, serum cobalt level, and urinary iodine excretion. Univariate and multiple logistic regression analyses were performed.

Results

The prevalence of grade 2 goiters was 34.8% (95% confidence interval [CI], 31.5 to 42.5), with both sexes being equally affected. The weight and body mass index of goitrous subjects was significantly lower (P<0.001) than those of nongoitrous subjects. The serum cobalt levels were lower in goitrous subjects than in nongoitrous subjects (4.4±2.9 µg/L vs. 6.4±2.7 µg/L). The urinary iodine levels were also lower in goitrous subjects than in nongoitrous subjects (198.3±108.3 µg/L vs. 270.2±91.1 µg/L). Multiple regression analysis showed that only cobalt deficiency, not iodine deficiency, significantly contributed to the presence of goiter (odds ratio, 0.78; 95% CI, 0.61 to 0.99; P=0.042).

Conclusion

Cobalt deficiency may be an important independent predicator for goiter in endemic regions, especially areas in which goiters persist despite salt iodization programs.

Citations

Citations to this article as recorded by  
  • Assessment of trace element and mineral levels in students from Turkmenistan in comparison to Iran and Russia
    Anatoly A. Kirichuk, Anatoly V. Skalny, Dirk Schaumlöffel, Irina A. Kovaleva, Tatiana V. Korobeinikova, Andrey S. Kritchenkov, Michael Aschner, Borhan Mansouri, Andrey A. Skalny, Alexey A. Tinkov
    Journal of Trace Elements in Medicine and Biology.2024; 84: 127439.     CrossRef
  • Cartographic evaluation of the risk of natural elements’ deficiency in the soil cover provoking spatial variation of the endemic morbidity level (on example of thyroid morbidity among population of the Central Federal District, Russia)
    Elena Mikhailovna Korobova, Vladimir Sergeevich Baranchukov, Jaume Bech
    Environmental Geochemistry and Health.2024;[Epub]     CrossRef
  • The effect of a drink enriched with iodine and hydrogen on iodine supply in patients with metabolic syndrome
    Romanenko
    Experimental and Clinical Physiology and Biochemistry.2022;[Epub]     CrossRef
  • INVESTIGATION OF ELEMENT COMPOSITION IN BIOSUBSTRATES IN ORGANISM OF ADOLESCENTS OF DIFFERENT ETHNIC GROUPS LIVING IN THE NORTH OF KHABAROVSK REGION
    A. O. Nesterenko, E. D. Tselik, G. P. Evseeva
    Bulletin Physiology and Pathology of Respiration.2019; (74): 62.     CrossRef
  • Trends over 1999–2014 in the concentrations of Ba, Cs, Co, Mo, Pb, Sb, Tl, and W in urine of US children aged 6–11 years
    Ram B. Jain
    Toxicological & Environmental Chemistry.2018; 100(1): 115.     CrossRef
  • Urinary iodine concentration (UIC) could be a promising biomarker for predicting goiter among school-age children: A systematic review and meta-analysis
    Linlin Xiu, Gansheng Zhong, Xueman Ma, Stephen L. Clarke
    PLOS ONE.2017; 12(3): e0174095.     CrossRef
  • Effects of Imbalance in Trace Element on Thyroid Gland from Moroccan Children
    Sana El-Fadeli, Sabir Bouhouch, Anatoly V. Skalny, Yassir Barkouch, Alain Pineau, Mohamed Cherkaoui, Azeddine Sedki
    Biological Trace Element Research.2016; 170(2): 288.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer
Age Is the Strongest Effector for the Relationship between Estimated Glomerular Filtration Rate and Coronary Artery Calcification in Apparently Healthy Korean Adults
Hyun Beom Chae, Shin Yeoung Lee, Nam Hee Kim, Ki Joong Han, Tae Hoon Lee, Choel Min Jang, Kyung Mo Yoo, Hae Jung Park, Min Kyung Lee, Won Seon Jeon, Se Eun Park, Heui-Soo Moon, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
Endocrinol Metab. 2014;29(3):312-319.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.312
  • 4,543 View
  • 35 Download
  • 7 Web of Science
  • 7 Crossref
AbstractAbstract PDFPubReader   
Background

Chronic kidney disease (CKD) is considered one of the most common risk factors for cardiovascular disease. Coronary artery calcification (CAC) is a potential mechanism that explains the association between renal function and cardiovascular mortality. We aimed to evaluate the association between renal function and CAC in apparently healthy Korean subjects.

Methods

A total of 23,617 participants in a health-screening program at Kangbuk Samsung Hospital were included in the study. Estimated glomerular filtration rate (eGFR) was assessed using the Cockcroft-Gault equation. Coronary artery calcium score (CACS) was measured via multidetector computed tomography. Subjects were divided into three groups according to the CKD Staging system with eGFR grade: stage 1, eGFR ≥90 mL/min/1.73 m2; stage 2, eGFR 60 to 89 mL/min/1.73 m2; and stage 3, eGFR 30 to 59 mL/min/1.73 m2.

Results

The mean age of the participants was 41.4 years and the mean eGFR was 103.6±21.7 mL/min/1.73 m2. Hypertension and diabetes were noted in 43.7% and 5.5% of the participants, respectively. eGFR showed a weakly negative but significant association with CACS in bivariate correlation analysis (r=-0.076, P<0.01). Mean CACS significantly increased from CKD stage 1 to 3. The proportion of subjects who had CAC significantly increased from CKD stage 1 to 3. Although the odds ratio for CAC significantly increased from stage 1 to 3 after adjustment for confounding factors, this significance was reversed when age was included in the model.

Conclusion

In early CKD, renal function negatively correlated with the degree of CAC in Korean subjects. Age was the strongest effector for this association.

Citations

Citations to this article as recorded by  
  • The Relationship of Fetuin-A with Coronary Calcification, Carotid Atherosclerosis, and Mortality Risk in Non-Dialysis Chronic Kidney Disease
    Osama Nady Mohamed, Mahmoud Ragab Mohamed Mohamed, Israa Gamal Hassan, Atef Farouk Alakkad, Ashraf Othman, Amr Setouhi, Ahmed S. Issa
    Journal of Lipid and Atherosclerosis.2024; 13(2): 194.     CrossRef
  • Coronary artery calcium and risk of chronic kidney disease in young and middle-aged adults
    Yejin Kim, Jeonggyu Kang, Yoosoo Chang, Young Youl Hyun, Kyu-Beck Lee, Hocheol Shin, Sarah H Wild, Christopher D Byrne, Seungho Ryu
    Nephrology Dialysis Transplantation.2023; 38(6): 1439.     CrossRef
  • New Model for Predicting the Presence of Coronary Artery Calcification
    Samel Park, Min Hong, HwaMin Lee, Nam-jun Cho, Eun-Young Lee, Won-Young Lee, Eun-Jung Rhee, Hyo-Wook Gil
    Journal of Clinical Medicine.2021; 10(3): 457.     CrossRef
  • Long-term effects of various types of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on changes in glomerular filtration rate in Korea
    Seo Yeon Baik, Hyunah Kim, So Jung Yang, Tong Min Kim, Seung-Hwan Lee, Jae Hyoung Cho, Hyunyong Lee, Hyeon Woo Yim, Kun-Ho Yoon, Hun-Sung Kim
    Frontiers of Medicine.2019; 13(6): 713.     CrossRef
  • Chronic kidney disease and coronary artery calcification in the Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil)
    Cheng Suh‐Chiou, Rosa M. Moysés, Marcio S. Bittencourt, Isabela M. Bensenor, Paulo A. Lotufo
    Clinical Cardiology.2017; 40(12): 1309.     CrossRef
  • Eligibility for Statin Treatment in Korean Subjects with Reduced Renal Function: An Observational Study
    Byung Sub Moon, Jongho Kim, Ji Hyun Kim, Young Youl Hyun, Se Eun Park, Hyung-Geun Oh, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Kyu-Beck Lee, Hyang Kim, Sung-Woo Park, Eun-Jung Rhee
    Endocrinology and Metabolism.2016; 31(3): 402.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer
Obesity and Metabolism
A Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and β-Cell Growth
Hee Young Kim, Jong-Ik Hwang, Mi Jin Moon, Jae Young Seong
Endocrinol Metab. 2014;29(3):320-327.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.320
  • 5,365 View
  • 65 Download
  • 10 Web of Science
  • 11 Crossref
AbstractAbstract PDFPubReader   
Background

Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced by cleavage of proglucagon in intestinal L-cells. In the pancreas, GLP-1 stimulates post-prandial insulin secretion, promotes insulin biosynthesis, and improves insulin sensitivity. Because of its insulinotropic activity, GLP-1 has been considered a good candidate drug for treatment of diabetes mellitus. However, clinical use of GLP-1 has been limited by its short half-life, as a result of rapid degradation by dipeptidyl peptidase-IV (DPP-IV).

Methods

We designed a novel GLP-1 analog, Xenopus GLP-1 (xGLP)-E4. The Ala residue in the second position of xGLP was replaced with a Ser residue to increase the half-life in the body. The C-terminal tail of exendin-4 was added to enhance the binding affinity for the GLP-1 receptor (GLP1R). The potency of GLP-1 and its analogs was determined by luciferase assay. The stability of GLP1R agonists was evaluated by determining the activity of agonists that had been preincubated in the presence of fetal bovine serum, which contains innate DPP-IV activity. The effects of xGLP-E4 on insulin secretion and β-cell growth were investigated using insulin enzyme-linked immunosorbent assay and cell counting.

Results

xGLP-E4 exhibited improved stability against DPP-IV activity and increased potency to GLP1R, compared with GLP-1. An increase in glucose-dependent insulin secretion was observed in xGLP-E4-treated pancreatic β-cells. The effect of xGLP-E4 on β-cell growth was greater than that of GLP-1.

Conclusion

We developed a novel GLP-1 analog, xGLP-E4, that shows prolonged longevity and improved efficacy. This analog is a potential candidate for treatment of type 2 diabetes.

Citations

Citations to this article as recorded by  
  • Novel GLP-1(28–36) amide-derived hybrid peptide A3 with weight loss and hypoglycemic activities
    Chen Wang, Binbin Gong, Qianqian Zhu, Jing Han, Lidan Sun
    European Journal of Pharmacology.2023; 961: 176200.     CrossRef
  • Intranasal Delivery of a Methyllanthionine-Stabilized Galanin Receptor-2-Selective Agonist Reduces Acute Food Intake
    Anneke Kuipers, Márta Balaskó, Erika Pétervári, Andreas Koller, Susanne M. Brunner, Gert N. Moll, Barbara Kofler
    Neurotherapeutics.2021; 18(4): 2737.     CrossRef
  • Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in ProtectingβCells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice
    Jing Xue, Yu Cheng, Haojie Hao, Jieqing Gao, Yaqi Yin, Songyan Yu, Junyan Zou, Jiejie Liu, Qi Zhang, Yiming Mu
    Stem Cells International.2020; 2020: 1.     CrossRef
  • DR10601, a novel recombinant long-acting dual glucagon-like peptide-1 and glucagon receptor agonist for the treatment of obesity and type 2 diabetes mellitus
    W. Wang, X. Wen, W. Duan, X. Wang, Y. Chen, J. Dong, Z. Yang, J. Fang, Z. Zhou, G. Yao, Y. Fang, Y. Huang
    Journal of Endocrinological Investigation.2020; 43(5): 653.     CrossRef
  • Evolutionary and Comparative Genomics to Drive Rational Drug Design, with Particular Focus on Neuropeptide Seven-Transmembrane Receptors
    Michael Furlong, Jae Young Seong
    Biomolecules & Therapeutics.2017; 25(1): 57.     CrossRef
  • Comparison of exenatide and acarbose on intra-abdominal fat content in patients with obesity and type-2 diabetes: A randomized controlled trial
    Li Shi, Jing Zhu, Ping Yang, Xiaoqiang Tang, Wenlong Yu, Changjie Pan, Moyu Shen, Dalong Zhu, Jinluo Cheng, Xinhua Ye
    Obesity Research & Clinical Practice.2017; 11(5): 607.     CrossRef
  • Mesenchymal stem cell therapy in type 2 diabetes mellitus
    Li Zang, Haojie Hao, Jiejie Liu, Yijun Li, Weidong Han, Yiming Mu
    Diabetology & Metabolic Syndrome.2017;[Epub]     CrossRef
  • Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling
    Mi Hae Seo, Jinmi Lee, Seok-Woo Hong, Eun-Jung Rhee, Se Eun Park, Cheol Young Park, Ki Won Oh, Sung Woo Park, Won-Young Lee, Catherine Mounier
    PLOS ONE.2016; 11(12): e0166913.     CrossRef
  • Development of Spexin-based Human Galanin Receptor Type II-Specific Agonists with Increased Stability in Serum and Anxiolytic Effect in Mice
    Arfaxad Reyes-Alcaraz, Yoo-Na Lee, Gi Hoon Son, Nam Hoon Kim, Dong-Kyu Kim, Seongsik Yun, Dong-Hoon Kim, Jong-Ik Hwang, Jae Young Seong
    Scientific Reports.2016;[Epub]     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Biased signalling: the instinctive skill of the cell in the selection of appropriate signalling pathways
    Ying Liu, Yang Yang, Richard Ward, Su An, Xiao-Xi Guo, Wei Li, Tian-Rui Xu
    Biochemical Journal.2015; 470(2): 155.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP